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     A central function of the Clinical Biochemistry or Chemical
Pathology laboratory is to provide biochemical information for
the management of patients. Biochemical tests are used
extensively in medicine, both in relation to diseases that have an
obvious metabolic basis (diabetes mellitus, hypo- or
hyperthyroidism, etc.) and those in which biochemical changes
are a consequence of the disease (malabsorption, renal failure,
etc.).
      Biochemical tests are used in diagnosis, prognosis,
monitoring and screening. Tests used primarily for diagnosis
may also provide prognostic information and some are used
specifically for this purpose. A major use of biochemical tests is
to  follow  the  course  of  an  illness  and  to  monitor  the  effects  of
treatment. Biochemical tests can also be used to detect
complications of treatment and are extensively used to screen for
possible drug toxicity, particularly in trials, but also in some
cases when a drug is in established use. Biochemical tests are
widely used to determine whether a condition is present
subclinically. The best-known example is the mass screening of
all newborn babies for phenylketonuria, which is carried out in
many countries.
    This book includes the Program, Systematic Indications and
Biochemical indices (parameters) of the blood serum, urine and
saliva. Systematic Indications have been composed according to
the Program and the new modern methods used in clinical
laboratories. Also in this book we included the special





Subject of Biochemistry. Biochemistry importance for medi-
cine. The greatest discoveries in Biochemistry in the XXth century.
Peculiarities of the alive matter, levels and methods of its study.
CHAPTER I. Protein structure
Amino acids: classes, structure, amphoteric and electro-che-
mical properties. Utility of amino acids in pharmacy and therapy.
Peptides and proteins, pro-tein’s classifications. Simple and con-
jugated proteins, brief characteristics. Peptide bond, genetic
changes of the amino acids sequence, hereditary proteinopathies
(molecular diseases). Levels of proteins organization: primary,
secondary, tertiary, quaternary structures and domains. Analysis of
protein conformation: Sanger's, Edman's methods, sequencing of
peptide fragments, X-ray crystallography, ultraviolet light spectro-
scopy, nuclear magnetic resonance. Properties of proteins: mole-
cular mass, thermolability, solubility, amphoteric and charge.
Structure-function relationships in proteins, selective interaction
with ligands, ligand’s recognition. Simple proteins: histones, al-
bumins, globulins, their functions and physico-chemical charac-
teristics. Conjugated (complex) proteins: nucleo-, chromo-, phos-
pho-, glyco-, metallo-, lipoproteins (brief characteristics).
Hemoglobin, collagen, immunoglobulins, Ca2+-binding proteins:
peculiarities of structure and function. Peculiarities of amino acid
composition in collagen, structure, properties and types of colla-
gens. Proteins solutions: types, properties and peculiarities. The pu-




Biological role of enzymes. Common properties and diffe-
rences from chemical catalysts. Structure of active center, role in
the catalytic act. Allosteric site: structure, role, modulators. Che-
mical nature of enzymes: simple and conjugated proteins. Cofac-
tors, coenzymes and prosthetic groups. The role of water–soluble
vitamins as coenzymes (B1,  B2,  B6,  B12, PP, folic acid, panto-
thenic acid, biotin, vit. C). Utility of provitamins and vitamins in
therapy.
Mechanism of enzyme catalysis. Regulation of enzymes: ac-
tivation (partial proteolysis, addition of cofactor, covalent modi-
fication, allosteric, quaternary autoassembling) and inhibition:
competitive (isosteric), noncompetitive, uncompetitive, allosteric,
product inhibition (retroinhibition). Utility in medicine of com-
petitive drugs (sulphanilamides, F-uracil, etc.).
Enzyme's properties: thermolability, pH influence, specifici-
ty (lock and key and induced-fit theories). Types of enzyme spe-
cificity.
Genetic diversity of the enzymes: isoenzymes (LDH, CPK).
Proenzymes. Organization of multienzymic systems. Compart-
mentalization.
Enzyme nomenclature. Measurement and measures of enzy-
mes activity. Methods of enzymes separation and purification.
Affinity chromatography.
Usage of enzymes assay in diagnostics. Enzymes as drugs.
Immobilized enzymes. The use of immobilized enzymes in the
thenological syntheses of a number of hormonal preparations as
drugs, and in high-sensitive analyses of drugs.
CHAPTER III. Nucleic acids
Structural components of the nucleic acids: nitrogenous ba-
ses, pentose sugar, phosphate group, their structure, properties.
Nucleosides and nucleotides: structure, nomenclature, role.
Cyclic nucleotides: cAMP (3’,5’cAMP) and cGMP (3’,5’cGMP).
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Types of the nucleic acids: DNA, RNA, their distribution in
the cell and biological role.
Nucleic acids structure. DNA structures: primary, secondary,
tertiary, nucleosomes, and chromatin. RNA structures: primary,
secondary and tertiary. Structure of tRNA. General aspects of
mRNA and rRNA structure.
Replication  (synthesis  of  DNA):  necessary  compounds,  the
multienzymic system, stages, DNA repair.
Transcription: necessary compounds, the multienzymic sys-
tem, stages. Post-transcription modification of mRNA. Reverse
transcription.
The genetic code and its properties. Mutations and muta-
gens. Genetic diseases. Inhibitors of proteins synthesis at differ-
rent levels. Genetic engineering, its means for biopharmacy and
medicine.
Translation (protein synthesis). Activation of the amino
acids: stages, enzymes, energy. Stages and mechanism of polype-
ptide chain synthesis. Post-translational modification of the pro-
teins. Peculiarities of collagen and immunoglobulins biosynthe-
sis. Protein folding. Control of protein synthesis in prokaryotes
and eukariotes. Usage of the drugs as inhibitors of replication,
transcription and translation in medicine.
CHAPTER IV. Introduction to metabolism
Metabolism, its stages: anabolism and catabolism. Stages of
catabolism: final common pathway, its importance.
Bioenergetics: thermodynamic concepts, enthalpy, entropy,
free energy, the standard state of the cell. Dehydrogenation: the
main energy sources in the human organism.
High-energy phosphate compounds. ATP: chemical structu-
re, importance, ATP-ADP cycle. Mechanisms of ATP biosynthe-
sis in nature: oxidative phosphorylation, substrate phosphorylati-
on, photophosphorylation (photosynthesis).
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The mitochondria structure. Oxidative decarboxilation of pi-
ruvate to acetyl-SCoA: multi enzymic complex, reactions, pro-
ducts, its regulation and interrelation with the Krebs cycle.
The tricarboxylic acid cycle (TAC, Krebs cycle): reactions,
enzymes, coenzymes, products, regulation, anaplerotic reactions,
interrelation with Respiratory Chain.
Mitochondrial electron transport chain (Respiratory Chain),
its types. Organization of the electron transport chain. Oxidati-
on–reduction (redox) potential and mechanism of ATP producti-
on. ATP formation sites, phosphorylation points. A coupling of
respiration with phosphorylation: oxidative phosphorylation, the
P/O ratio. Chemiosmotic or proton-driving hypothesis Mitchell.
Uncouples of oxidative phosphorylation. Agents affecting energy
metabolism in cells (hormones, drugs, toxins).
Microsomal oxidation: microsomal electron transport chains
(NAD-dependent and NADP-dependent chains), their organizati-
on. Role of cytochrome P450. Radical species of oxygen and lipid
peroxidation. Protective antioxidative systems: enzymic and no-
nenzymic. Vitamins-antioxidants as drugs and their use in medi-
cine.
CHAPTER V. Carbohydrate chemistry and
metabolism
Definition, classifications, nomenclature and chemical struc-
ture of carbohydrates. Properties of the most important monosac-
charides, disaccharides, polysaccharides and carbohydrate deri-
vatives.
Digestion and absorption of carbohydrates (sugars) into gas-
tro-intestinal tract.
Glycogen metabolism: reactions, enzymes, neuro-hormonal
regulation of glycogen biosynthesis and glycogenolysis. Genetic
defects in glycogen metabolism (Von Gierke, Pompe, Forbes dis-
eases, etc.).
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Glycolysis: stages, reactions, enzymes and coenzymes, enzy-
mic control of glycolysis. Anaerobic glycolysis: production ATP
as substrate phosphorylation. Aerobic glycolysis (aerobic oxida-
tion  of  glucose):  high-energy  phosphate  (ATP)  production,  role
of a-glycerophosphate and malate-aspartate shuttle mechanisms.
Energy balance of glucose oxidation (to CO2 and H2O).
Gluconeogenesis: the gluconeogenic pathway, energetics
and substrates for gluconeogenesis. The Cory and alanine cycles.
Hormonal control of gluconeogenesis and its pathology.
Pentose phosphate (apotomic) pathway or shunt: functional
significance, chemical reactions for pentoses production, regula-
tion and biorole.
Metabolism of fructose, galactose and lactose: pathways,
significance and hereditary defects. Biosynthesis of lactose: path-
way, control and functional significance. Glucuronic acid cycle:
significance, pathway. Alcohol fermentation: reactions, energetic
output, significance.
Regulation of carbohydrate metabolism: metabolic and hor-
monal control of the blood serum glucose concentration in heal-
thy and in patients. Diabetes mellitus: metabolic disturbances,
mechanism hyperglycemia, glucosuria, ketonemia, ketonuria, di-
abetic coma.  Drugs used for correction of diabetes mellitus.
CHAPTER VI. Lipid chemistry and metabolism.
Nature, functions, classifications, structure and properties of
fatty acids, acylglycerols, phosphoglycerides, sphingomyelin,
sphingolipids, cholesterol and its esters. Fat-soluble vitamins  (A,
E, D, K): structure, biorole, disorders caused by their deficiency.
Fat-soluble (liposoluble) vitamins as drugs and antioxidants.
Membrane structure (Sanger-Nicolson) and functions. Com-
position and characteristics of membrane components, their pro-
perties and diversity, selective permeability and transport sub-
stances through the cell membranes.
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Digestive mechanism for the lipids and absorption in gastro-
intestinal tract. Structure, functions and metabolism of the bile
acids. Re-esterification, formation of chylomicrons, transport.
Lipoproteins metabolism, clinical disorders of lipoproteins meta-
bolism.
Lypolysis of triacylglycerols in tissue: enzymic steps, hor-
monal control of lipolysis in the different tissues and its disor-
ders.
Fatty acid b-oxidation: reactions, enzymes and coenzymes,
final products, high-energy phosphate (ATP) production, stoi-
chiometry of b-oxidation. The specific behaviour of odd-numbe-
red and unsaturated fatty acids. Alternative pathways for the fatty
acid oxidation.
Glycerol oxidation: the enzymic steps, ATP production, in-
terrelation with glycolysis.
Biosynthesis of fatty acids: characteristics of polyenzymatic
complex, steps, source of acetyl-CoA and NADPH+.
 Ketone bodies metabolism: nature of the ketone bodies,
ketone bodies production and oxidation. Energy (ATP) producti-
on during oxidation of the ketone bodies. Ketoacidosis.
Cholesterol metabolism: site, steps and carbon sources for its
synthesis. The first step of the cholesterol synthesis (to mevalo-
nic acid), regulation. Esterification of cholesterol as precursor of
other compounds (bile acids, steroid hormones and vitamins).
Cholesterol excretion from the human organism. Connection bet-
ween cholesterol and blood plasma lipoproteins metabolism. Dis-
orders of the cholesterol metabolism: hypercholesterolemia, cho-
lelithiases (gallstones formation) and atherosclerosis.
Phosphoglycerides metabolism. Biosynthesis de novo and
salvage pathway: reactions, regulation, lipotropic factors. Con-
vertion of phosphatidylserine to other phospholipids (phosphati-
dylethanolamine, phosphatidylcholine). Modification and oxida-
tion of phospholipids.
Sphingolipid’s, chemical structure, biorole. Sphingolipids’
biosynthesis: formation of sphinganine, ceramide, sphingomyelin,
11
glycosphingolipids. Catabolism of sphingolipids. Lipidoses due
to impaired ganglioside catabolism. Disorders of sphingomielin
metabolism (Niemann-Pick, Gaucherie, Fabry diseases).
Prostaglandins and related compounds: general features and
biologic role, nomenclature,  structure and biosynthesis. Biologi-
cal role in health and pathology.
Disorders linked to lipid metabolism: dislipemia and lipido-
ses.
Chapter VII. Metabolism of simple and conjugated
proteins
Protein turnover. The amino acid pool: notion inputs and
outputs. Essential amino acids. Nitrogen balance, its types.
Proteins digestion: role of HCl and proteolytic enzymes
(endo- and exopeptidases). Proteases: secretion, mechanism acti-
vation, regulation and specificity. HCl role, mechanism of secre-
tion and its regulation. Gastric juce acidity assay: hypochlorhyd-
ria, hyperchlorhydria. Amino acids absorption into small intes-
tine: Na+-simport mechanism and g-glutamate cycle. Bacterial
putrefaction of the amino acids in large intestine: production of
toxic compounds (indol, scatol, cresol, cadaverine, putrescine,
etc.) and their inactivation in the liver. Mechanism of conjugati-
on, production of indicane, its diagnostic means. Examination of
the antitoxic function of the liver.
Proteolysis (catabolism) of proteins in the tissues, its regula-
tion.
Amino acids degradation (intracellular catabolism). The dis-
posal of amino acids nitrogen: oxidative deamination (direct and
indirect), enzymes, coenzymes, biologic role.
Transamination  of  the  amino  acids;  role,  enzymes,  coenzy-
mes and mechanism of the reaction. Medical usage of aminotran-
sferases' activity assay:  alanine transaminase (ALT) or glutamic
pyruvic transaminase (GPT) and aspartate transaminase (AST) or
glutamic oxaloacetic transaminase (GOT).
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Amino acids decarboxylation, enzymes, coenzymes, final
products. Biogenic amines: serotonine, histamine, dopamine and
g-aminobutyric acid (GABA), their biological activity and inacti-
vation. The fate of the amino acids carbon skeletons.
Ammonia production and toxicity. Overall flow of nitrogen.
The urea cycle, reactions, regulation and importance. Interrelati-
onship between urea and TCA (Krebs) cycles.
Specific metabolic pathways of amino acids: gly, ser, thr,
cys, met, phe, tyr, trp, glu, asp. Amino acids as major inputs to
the one–carbon pool and precursors of biological important com-
pounds.
Molecular diseases associated with abnormal amino acid
metabolism (molecular diseases): Hartnup’s disease, phenylketo-
nuria, tyrosinemia, alkaptonuria, maple syrup urine disease, etc.
Nucleoprotein metabolism: digestion and absorption in small
intestine. Nucleotide turnover. De novo synthesis of purine and
pyrimidine nucleotides: substrates, pathways, regulation. Deoxy-
ribonucleotide formation. Salvage pathway for purine and py-ri-
midine bases. Conversion of the MNP to DNP and TNP. Degra-
dation of purine and pyrimidine nucleotides. Diseases associated
with defects of nucleotide metabolism (gout, orotic aciduria).
Hemoprotein metabolism. Digestion and absorption of he-
moglobin in gastro-intestinal tract. Biosynthetic pathway of the
heme and hemoglobin, regulation of the hemoglobin synthesis.
Drugs as activators of the hemoglobin synthesis. Hemoglobin de-
gradation in the tissues. Iron (Fe) metabolism. Genetic disorders
of the heme biosynthesis (porphyrias). Hiperbilirubinemia and
jaundices, types, biochemical diagnostics.
CHAPTER VIII. Hormones
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The hierarchy of the regulatory systems in the human orga-
nism. Hormone’s place in the hierarchy of the metabolism regu-
lation and physiological functions.
Classification and mechanisms of hormone’s action. The hor-
mone-receptor interaction. The receptor-adenylate cyclase com-
plex: 3’,5’-cyclic AMP function, cyclic AMP-dependent protein
kinase and phosphorylation of the cellular proteins. Diacylglyce-
rol and inositol-1,4,5-triphosphate – the second messengers of
the hormones. Role of protein kinase and Ca2+ in hormonal func-
tion.  Calmodulin  –  structure  and  role.  General  mechanisms  of
hormones  biosynthesis,  release  and  their  regulation.  Central  re-
gulation of the hormone functions: role of hypothalamus (neuro-
hypophysis) and adenohypophysis.
Hypothalamic hormones: liberins (releasing hormones, RH)
and statins (releasing inhibiting hormones, RIH), chemical struc-
ture, biological role.
Hypophyseal (pituitary) hormones: representatives (somato-
tropin, corticotropin, thyrotropin, et al.), structure, function, di-
seases associated with pituitary disorders and their correction.
Vasopressin and oxytocin: chemical structure, metabolic
effects. Diabetes insipidus, its manifestations. Utility of oxytocin
in medicine.
Thyroid hormones: T3 and  T4, structure, biosynthesis, me-
chanism of action, release, transport, metabolic effects, disorders.
Parathyroid hormones: structure, biosynthesis, mechanism of
action, release, transport, metabolic effects. Interrelation of para-
thyrin with other compounds, that regulate calcium and phospha-
te metabolism. Role of 1,25-dihydroxycholecalciferol for para-
thyroid hormone action. Disorders of parathyroid glands functi-
ons.
Pancreatic hormones: insulin and glucagon, structure, bio-
synthesis, mechanisms of action, release, transport, metabolic
effects. Mechanism activation and inactivation of insulin. Diabe-
tes mellitus: causes, types (I and II), metabolic changes in the pa-
tients and their correction.
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Catecholamine hormones (adrenalin, noradrenalin): structu-
re, biosynthesis, release, transport, metabolic effects, disorders.
Glucocorticoids hormones: structure, biosynthesis, release,
transport, metabolic effects, disorders. Steroid diabetes, metabo-
lic disorders.
Mineralocorticoids hormones: structure, biosynthesis, relea-
se, transport, metabolic effects, disorders.
Sexual hormones (androgens, estrogens): structure, biosyn-
thesis, release, transport, metabolic effects, disorders.
Utilisation of hormones and antihormones as drugs in medi-
cine for substitution therapy and pathogenetic therapy.
CHAPTER IX. Blood
Blood functions and physico-chemical properties.
Blood cells: peculiarities of the composition, metabolism of
erythrocytes, leucocytes, lymphocytes and thrombocytes. Func-
tion – metabolism relationships.
Plasma organic compounds: proteins and enzymes, non-
proteic nitrogen substances, residual nitrogen, carbohydrates,
lipids and organic acids. The major proteins of blood plasma:
brief characteristics, methods of separation and assay. Hypo-,
hyper-, dis- and para-proteinemias: notion, causes and examples.
Oncotic pressure and its disorders, reasons and correction.
Blood enzymes: classifacation, practical utility. Indicator
(organ specific) blood enzymes in liver and heart diseases. Me-
chanism of enzymes’ level increasing in the blood serum.
Plasma non-proteic nitrogen compounds. Hyperammonemia
and hyperuremia, causes, consequences. Bilirubin: types, forma-
tion, excretion in the healthy human organism. Disorders of
hemoglobin’s catabolism: icteric syndrome (types, causes, disor-
ders of bilirubin conjugation, its excretion and clinical laboratory
diagnostics).
Inorganic compounds: the major anions, cations and microe-
lements, their role.
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Mechanisms of oxygen and CO2 transport, biochemical me-
chanisms of respiration function of blood. Functional requireme-
n-ts to hemoglobin and cooperative binding of oxygen, role of
2,3-diphosphoglycerate in this process. Role of carboanhydrase
in  gases  transport  in  the  blood.  Disorders  of  gas  transport  (me-
chanisms, diseases). Hypobaric and hyperbaric oxygenation, its
usage in medicine.
Acid-base equilibrium: buffer systems and physiological
mechanisms of buffering. Disorders of acid-base equilibrium of
the blood: alkaloses and acidoses, types, diagnostics and mecha-
nisms of buffering correction.
Fluid-coagulation equilibrium. Biochemical mechanisms of
blood clotting: plasmic and platelets coagulation factors (brief
characteristic). Extrinsic and intrinsic mechanisms of blood clot-
ting: causes, timing and cascade mechanism. Fibrinolitic and an-
ticoagulant mechanisms. Natural and synthetic anticoagulants,
their mechanism of action and usage in medicine. Role of vita-
mins K and D in the blood coagulation. Native and synthetic an-
ticoagulants (antivitamins K: pelentan, dicumarol, etc.), utility in
medicine.
Chemical components of the blood as drugs (albumin, gam-
ma-globulin, interferon, etc.).
CHAPTER X. Stomatological biochemistry:
connective, bone and dental tissues. Biochemistry of
saliva
Types and functions of the connective tissue. Main compo-
nents of the connective tissue: cells (representatives, biological
role) and extracellular matrix (structural elements and their bio-
logical role).
Fibrilar proteins of the connective tissue (collagen, elastin):
the particularities of chemical composition, structure and proper-
ties. The peculiarities of collagen biosynthesis, post-synthetic
(post-translation) modifications and degradation.
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Glucosamine glycans (heteropolysaccharides or mucopoly-
saccharides) of the extracellular matrix of the connective tissue:
main representatives, their structure, biological role. Proteogly-
cans and glycoproteins, their biological role.
Physiological and pathological modifications of the connec-
tive tissue metabolism: age-dependent modifications, acquired
disorders (hypovitaminosis C, diabetes mellitus). Genetic disor-
ders: collagenoses, mucopolysaccharidoses, biochemical mani-
festations.
Structure  and  role  of  the  bone  tissue.  The  cells  of  the  bone
tissue: the representatives, their biological role. Organic compo-
unds of the bone tissue: fibrilar and non-fibrilar proteins, proteo-
glycans, carbohydrates, lipids.
Mineral components of the bone tissue: main anions, cations,
their structural organization, minor ions, olygoelements. Appati-
te: components, structure and properties.
Bone formation and resorbtion: cells, that participate in these
processes, the stages and mechanisms of the processes. Regulati-
on of the bone tissue metabolism in the human organism. Role of
the thyroid and parathyroid glands’ hormones and vitamins D
and C for the bone  metabolism. Pathology of the bone metabo-
lism: age-dependent, osteoporosis.
Dental tissues: general characterization and role. Teeth tissu-
es (enamel, dentine, cementum) structural organization and gene-
ral characteristics. Organic and mineral components of dental tis-
sues.  Normal  biochemical  processes  in  the  teeth.  Role  of  vita-
mins A, D, C in the metabolism of dental tissues and the soft tis-
sues of the mouth. Calcium, phosphorus and fluor metabolism:
main alimentary sources, mechanisms of absorption into intesti-
ne, blood transport, excretion, role in the dental tissue metaboli-
sm and in the teeth pathology.
Biochemical processes that take place during the dental cari-
es development.
Periodontium: the main chemical compounds, their characte-
ristics and biological role. Physiological biochemical processes
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of the periodontal tissues. Biochemical processes that take place
in the pathology of the periodontium, role of the inflammation
mediators and immune system. Dental plaque: chemical compo-
sition, main biochemical processes in the plaque, the correlation
with the periodontal pathologies (gingivitis, parodontitis, paro-
dontosis).
Gingival liquid: causes of the apparition, chemical composi-
tion and its role.
Saliva: sources, chemical composition, physico-chemical
properties  and  role.  Clinical  diagnostic  means  of  the  salivary
components for medicine and dentistry.
CHAPTER XI. Pharmaceutical Biochemistry.
Metabolism of drugs. Photosynthesis
Natural biological active peptides: anserine, carnosine, an-
giotensine, secretin, endothelin, hormones. Antibiotics as protein
derivatives.
Biological role of water in the human organism (functional
and structural one). Physico-chemical properties of water. Water
as solute for natural substances and xenobiotics.
Metabolism of drugs and xenobiotics in organism. Relation
between metabolism of the drugs and their chemical structure.
Localization of the drug metabolism in the organism (enteral, ex-
tracellular, cellular). Stages of the xenobiotics metabolism (mo-
dification and cojugation).
Conjugation of xenobiotics: I type (glucuronide, sulphate, a-
cetyl conjugations) and II type (a prior activation of the substra-
te-xenobiotic) conjugation. Enzymes involved in the metabolism
of xenobiotics in the human organism. Metabolism of drugs and
toxins (poisons).
Microsomal oxidation of substances and xenobiotics (mono-
oxigenase and reductase chains). Role of cytochrome P450 in this
process. Drugs-activators of cytP450 production in the organism.
Conditions for drug metabolism. Biotechnology of drugs. Bio-
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chemical methods used in drug standardization and quality con-
trol.
Photosynthesis and characteristics of the photosynthetic
structures – chloroplasts. Chlorophyll (major structural characte-
ristics) and its role in photosynthesis.
Photosynthesis basis: mechanism of the light (photochemi-
cal) and dark (synthetic) stages. Cyclic and noncyclic transport
of electrons in the photochemical stage of the photosynthesis.
Water photolysis, Hill reaction. The role of photosystems I and II
in the photosynthesis.
Photophosphorylation (ATP production in chloroplasts) and
oxidative phosphorylation in mitochondria, common characteri-
stics and differences. The role of the Calvin cycle in the synthe-
sis of polysaccharides. Photosynthesis as a way for the buildup of




Proteins of the human organism are linear, unbranched poly-
mers  constructed  from  20  different  L,a-amino acids linked by
peptide bond and encoded in the DNA of the genome. Proteins
are involved in enzymatic catalysis, transport and storage of
small molecules and ions, systematic movements, immune defen-
se, hormonal regulation, control of genetic expression, etc.
Every protein in its native state has a unique three-dimensio-
nal structure that is referred to as its conformation. Protein struc-
ture can be classified into four levels of organization: primary,
secondary, tertiary and quaternary structures. Based on confor-
mation proteins are divided into two classes: globular and fibrous
proteins. Based on their composition proteins are divided into
simple and complex (conjugated) proteins:  hemo-, glyco-, lipo-,
phospho-, nucleo- and metaloproteins.
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Proteins are large molecules, with molecular weight ranging
from 10 to 50 kDa for singlechain proteins and from 150 to 200
kDa for multichain (oligomeric) proteins. Proteins have ampho-
teric properties, are optically active and soluble.
Separation of a protein from other proteins or from smaller
molecules is achieved by applying a combination of several me-
thods based on properties such as  molecular size, electrical char-
ge, solubility and specific binding of the protein to a specific
substance. Separation procedures are salting, dialysis, ultracentri-
fugation, chromatography, and electrophoresis. Analyses of pro-
teins begin with determination of the amino acid composition by
hot acid hydrolysis and ion exchange chromatography separati-
on. The amino acid sequence is identified by Edman reaction or
sequencing of peptide fragments. The secondary, tertiary and
quaternary structures are studied by X-ray crystallography, ultra-
violet light spectroscopy, nuclear magnetic resonance, etc.
LESSON 1
Introduction to Biochemistry. Biochemistry in medical
and pharmaceutical education.  Amino acids
Experiment 1. Biuret reaction (Piotrovskii).
Method principle. Peptidic bonds react with CuSO4 in alkali-
ne conditions to form red-violet complex compounds
Procedure: Mix the reagents according to the table.
№ Reagents Test tube
1 Ovalbumine, 1% 5 drops
2 NaOH, 10% 5 drops
3 CuSO4, 1% 2 drops
Shake thoroughly
Conclusion:
Experiment 2. Ninhydrin reaction.
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Method principle. Ninhydrin reacts with a-amino groups of
amino acids and proteins to form a blue-violet compound.
Procedure: Mix the reagents according to the table.
№ Reagents Test tube
1 Ovalbumine, 1% 5 drops
2 Ninhydrine 0,5% 5 drops
Boil the solution for 1-2 min
Conclusion:
Experiment 3. Xantoproteic reaction (Mulder).
Method principle. Boiling the solution of the aromatic amino
acids with concentrated HNO3 produces the nitrates’ yellow-co-
lored complex. The addition of alkali changes the coloured com-
plex to orange.
Procedure: Mix the reagents according to the table.
№ Reagents Test tube
1 Ovalbumine, 1% 5 drops
2 HNO3 concentrated 5 drops
Mix and boil for a few minutes
Cool the solution
3 NaOH, 20% 10 drops
Conclusion:
Experiment 4. Unoxidized sulfur test (Fol).
Method principle. This  is  a  test  for  the  presence  of
sulfurcontaining amino acids. The protein or amino acid is boi-
led with strong alkali to split out sulfur as sodium sulfite (Na2S),
which is detected by addition of sodium leaden (Na2PbO2 ), whi-
ch causes the formation of brown to black lead sulfide (PbS).
The sequence of reactions may be represented as follows:
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1.  CH2-SH                                CH2-OH
     |                                             |
    CH-NH2       +  NaOHà     CH-NH2  + Na2S + H2O
     |                                   +to     |
    COOH                                  COOH
   cysteine
1.  Na2S + N2PbO2 + 2 H2Oà  PbS¯ + 4 NaOH
                                                 black colour
This  reaction  is  a  test  for  cystine  and  cysteine,  but  not  for
methionine, which contains firm-binded sulfur.
Procedure: 5 drops of protein solution (1%) and 5 drops of
Fol’s solution carry into test-tube, mix and boil for 1-2 min.
Conclusion:
Self-training questions
1. Biochemistry, role of the biochemical investigations for
            medicine.
2. Biological role of proteins.
3. Chemical structures and classifications of amino acids.
4. Polypeptide theory of the protein structure. “N”-end and
            “C”-end of amino acids of the polypeptides.
5. Peptides and their therapeutic utility (anserine, carnosin,
            glutathione, anhiotensin, kinins, secretin, endothelin,
            hormons).
6. Antibiotics of protein nature.
Self-testing questions:
1. Write and name the following peptides: his-phe-cys; tyr–
            pro-arg. Which of the coloured reactions will be positive
            or negative?
2. Is the compound a protein? Explain, please.
a) its reaction with ninhydrine is negative and with
                  biuret reagent is positive;
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b) it gives the positive Fol reaction.
3. Is it possibly to identify an amino acid in solution only by
            ninhydrin reaction? Explain.
4. A mixture contains the amino acids: gly, ala, glu, lys, arg,
            ser. Which electrode each of them will move to at pH=
            6,0? Explain.
5. Which electrode histidine will move to at pH=4.0 and
            pH=12.0? Explain.
LESSON 2
Proteins: chemical structure and biological role.
Chromatographycal method for identification of amino
acids
Experiment 1: Chromatographycal identification of the
amino acids.
Method principle: Amino acids have different distributive
coefficient in water and organic solvent (butanol). Amino acid’s
velocity of migration is directly proportional to their solubility in
butanol.
Procedure:
Mark the take-off line on the chromatographycal paper. Fall
a drop of amino acids mixture in the middle of the starting line
(the diameter of the spot must be less then 5 mm), dry the spot.
Introduce the chromatographycal strip in a vessel with the sol-
vents mixture (water-butanol). The strip must be in vertical posi-
tion and not touch the vessel.
Take out the strip after 90 min, mark the distance passed by
the solvent and dry the chromatogram (10 min at 70-100º C).
Pass the strip through 0,1-0,2% ninhydrin solution and dry it at
100º C. On the strip were develop several coloured spots.
Measure the following distances:
 a - from the take-off line to the middle of each spot;
 b - from the take-off line to the solvent's front.
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Calculation:
Calculate the distributive coefficients for each amino acid
using the next formula:
                              Rf = a/b.
Rf1= a1: b =                 Rf2= a2 : b =                Rf3 = a3 : b =
Conclusion:
Clinical-diagnostic means: This method allows to determine
quality and quantity of amino acids in different biological sam-
ples (blood serum, urine, etc.). Assays for amino acids content
and composition are indispensable in clinical diagnosis of nume-
rous inborn errors of metabolism, liver and kidneys diseases, etc.
Self-training questions
1. Protein levels of organization: primary, secondary, terti-
            ary and quaternary structures. Specific chemical bonds
            for stabilization of each structure. Domains, folding and
            refolding of proteins molecules. Biological active
            peptides.
2. Analysis of protein conformation (determination of the a-
            mino acid composition, N- and C-terminal amino acids,
            the amino acid sequence, secondary, tertiary  and
            quaternary structures).
3. Proteins classification.
4. Simple proteins: general characteristic, structural peculia-
            rities.
5. Collagen: peculiarities of amino acids composition and
            structure.
6. Conjugated (complex) proteins: nucleo-, phospho-, lipo-,




1. Fill in the table the bonds that are characteristic to each
structural level of the protein.




2. Why histones are basic proteins and albumins – acidic?
            What are their charges (positive or negative) at
             physiological pH?
3. Write down the formulas of untypical amino acids that
            are present in the collagen primary structure. Which are
            their specific functions in this protein?
4. How Ca2+ ions are attached to the Ca2+-binding proteins?
LESSON 3
Physico-chemical properties, purification and analysis of
proteins
Experiment 1. Dialysis of proteins.
Method principle. Dialysis (from the greek dialisis – separa-
tion) is a method of separation based on the molecular size.
Small molecules can be removed from solutions because they
pass through semipermeable membranes. Proteins are larger than
the pores of the membrane and don't cross it.
Procedure: Mix in a retort 20 ml of ovalbumin and 20 drops
of (NH4)2SO4 solution (saturated one). Put the solution in a cello-
phane bag and immersed it into water in a glass. In 60 min pull
out the bag and transfer the solution into a test-tube. Identify pro-
tein and (NH4)2SO4 in both solutions and write the result in the
table.





a) The presence of protein is determined by biuretic reaction.
Conclusion:
b) The presence of (NH4)2SO4 is determined with BaCl2
solution. Transfer 5 drops of solution from the glass into
            the test-tube and add 3-4 drops of BaCl2, 5%. Formation
            of insoluble BaSO4 certified the presence of SO42-ions.
BaCl2 + (NH4)2SO4 ®   BaSO4¯
Conclusion:
Experiment 2: Protein precipitation (sedimentation).
Protein can be precipitated by denaturation. Proteins are de-
naturated by action of physical and chemical factors such as heat,
radiation, concentrated acids or bases, etc. Denaturated proteins
loose its three dimensional structures and therefore are insoluble.
a) Method principle: Proteins are precipitated by metals





1 Ovalbumin, 1% 5 drops 5 drops
2 CuSO4, 1% 2 drops –
3 Pb(CH3COO)2 , 5% – 2 drops
Conclusion:
b) Method principle: Proteins are precipitated by acids.
Procedure: Put  in  the  1st test–tube 10 drops of HNO3
concentrated and in the 2nd test-tube – 10 drops of H2SO4
concentrated. Warm up the test-tubes to 45o C and carefully add
10 drops of ovalbumin in each ones.
Conclusion:
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Experiment 3: Separation of albumins and globulins
from ovalbumin solution.
Method principle. Adding bivalent salts, such as ammonium
sulfate, to a solution of proteins mixture will precipitate some
proteins at a given salt concentration, but not the others. The
procedure is named as salting-out. Globulins are salted out by
semisaturated solution of ammonium sulfate and albumins – by
the saturated solution.
Procedure: To 20 drops of undiluted solution of ovalbumin
add 20 drops of saturated (NH4)2SO4 solution. The solution will
be semisaturated and therefore globulins will precipitate from it.
In 5 min incubation at the room temperature this solution filtrate
using a moisten paper-filter. After that add crystalline ammo-
nium sulfate to the filtrated solution and mix it until saturation
and albumins precipitation. The solution is filtrated again. Carry




1. Physical and chemical properties of proteins: molecular
            mass, protein solubility, colloidal, acid-basic
            (amphoteric), osmotic.
2. Protein solubility. Correlation between solubility of a pro-
            tein and its amino acids composition and conformation.
3. Protein colloidal solutions: properties, factors affecting
            the protein solubility. Variants of colloidal solutions: gel,
            zol, xerogel.
4. Electric charge of the protein. The isoelectric point and
            isoelectric state of proteins.
5. Denaturation of proteins. Factors causing denaturation.
           Coagulation of proteins.
6. Methods used for isolation and purification of proteins:
            dialysis, ultrafiltration, salting-out, electrophoresis,
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         chromatography, gel-filtration.
Self-testing questions:
1. Why is the iso-electric point of the majority proteins in
            acidic medium, except histones?
2. Which is electrode for histones migration loading in the
            middle of the strip and buffer solutions with pH 4,0 and
            9,5?
3. What happenes to a protein molecule in hydrolysis, coa
             gulation, and denaturation?
4. Why are alcohol, iodine solution used for disinfecting the
             surgical field?
5. What methods of protein purification and analysis are ba-
            sed on: a) molecular size; b) molecular charge; c) specific
            affinity binding?
CHAPTER II
Enzymes
Enzymes are biological catalysts. They are neither consumed
nor produced during the course of a reaction. They speed up rea-
ctions that would ordinarily proceed, but at a much slower rate in
their  absence.  In  other  words,  they  do  not  alter  the  equilibrium
constants of reactions they catalyze.
Enzymes are invariably globular simple or complex (conju-
gated) proteins. If the enzyme is a simple protein, only the native
conformation of a protein is required for activity. If the enzyme
is a conjugated protein, activity will depend upon both the pro-
tein's conformation and the availability of cofactors. As cofactors
for enzymes may be used metals (particularly transition elemen-
ts), organic compounds (nucleotides, hem, glutathione, etc.) or
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active forms of vitamins. If the cofactor is strongly bounded to
the enzyme proteinic portion it is called prosthetic group. If it
can reversibly dissociate from the enzyme proteinic portion, it is
called coenzyme.
Each enzyme has an active site that turns the given reactants,
or substrates, to products. The enzyme decreases the energy of
activation of the reaction so a certain proportion of substrate
molecules are sufficiently energized to reach the so-called transi-
tion state, in which there is a high probability that a chemical
bond will be made or broken to form a product.
The rate of a reaction depends on the substrate and enzyme
concentrations, pH and temperature conditions, presence of diffe-
rent regulatory factors (allosteric modulators, acceptors, products
of reaction, hormones, etc.).
Enzymes activity is inhibited by compounds that are structu-
rally related to the substrate and capable of preventing the forma-
tion of an enzyme-substrate complex (competitive inhibition), or
alternatively compounds that can modify the active site (non-
competitive inhibition), or the conformation of the whole mole-
cule (allosteric inhibition).
The assay of enzymes in the serum of peripheral blood is
used as an important aid to diagnosis.  The level of activity of a
number of enzymes is raised in different pathological conditions
as a result of cells damage. The rate of enzyme activity depends
on the composition of the cells and the state of the tissues.
LESSON 4
Enzymes nature and structure. Classifications.
Vitamins as coenzymes.
Mechanism of enzyme catalysis
Experiment 1: Examination of saliva a-amylase’s
chemical properties.
For execution of this task it is necessary to know:
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a) a-amylase hydrolyzes starch and glycogen to maltose
through a series of dextrins, which may be coloured by iodine.
Maltase acts on maltose to form glucose only. Glucose in alkali-
ne solution is a very powerful reducing agent. This reducing acti-
on of glucose in alkaline solution is utilized for both the qualitati-
ve  and  quantitative  determination  of  glucose.  Reagents  contai-
ning Cu-ions are the most commonly used (Trommer reagent).
Trommer chemical reaction:
1. Cu2SO4  +  2 NaOHà Cu(OH)2  +  Na2SO4
2. R-COH   +  2Cu(OH)2 à R-COOH   +  2CuOH  + H2O
    aldehyde     blue colour          acid         cuprous hydroxide
    (glucose)                                                   (yellow)
3.  2CuOH à   Cu2O +  H2O
       yellow         red precipitate
b) pepsin is a peptidase, which hydrolyzes a-amilase as
any other protein in the strong acidic medium (HCl).
c) Starch with iodine forms a blue-coloured complex.
Procedure:
Step   1
Reagents (ml)                     Control                      Test
1. Saliva (a-amylase)                      1                                 1
2. Pepsin (in HCl solution)             –                                  1
3. Solution of HCl                           1                                  –
                 Incubation: at temperature +38o C, 10 min
                                           Step 2
4. Solution of starch                        1                                 1
                Incubation: at temperature +38o C, 10 min
5. Iodine solution (drops)                1                                 1
Colour with iodine:
 Conclusion (about saliva a-amylase nature):
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Experiment 2: Vitamin B2 identification.
Method principle: Solution of the oxidized form of ribofla-
vin is yellow-coloured. At the beginning of the reduction reacti-
on  the  colour  turns  rose  and  the  solution  becomes  colourless
when all the molecules are reduced.
Procedure:
№ Reagent Test-tube
1 Riboflavin solution 10 drops
2 Concentrated HCl 5 drops
3 Metallic Zn 1-2 granules
Note:
H2 gas is eliminated at the beginning of the reaction.
Conclusion:
Experiment 3: Vitamin PP identification.
Method principle: When nicotinamide and nicotinic acid are
treated with copper acetate at a high temperature, the blue sedi-
ment of the copper salt of niacin is formed.
Procedure:
№ Reagent Test-tube
1 Vitamin PP solution 20 drops
2 Boil the solution so the turbidity will disappear
3 Solution of Cu(CH3COO)2 ,5% 20 drops
4 Boil the mixture
5 Cool the mixture in a glass of cold water
Conclusion:
Self-training questions:
1. Enzymes: definition, function. Properties of the enzymes,
            biological role.
2. Enzymes nature, evidences of proteic nature. Structure of
            enzyme: active and allosteric sites. Proenzymes.
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3. Simple and conjugated enzymes. Isoenzymes.
4. Cofactors for enzymes: coenzymes and metal ions. Vita-
            mins as coenzymes.
5. Structure and biological role of vitamins B1, B2, B6, B12
           (only notions about its structure), C, PP, biotin,
           pantothenic and folic acids.
6. Vitamins as pharmaceutic preparations, use in medicine.
7. Mechanism of enzyme catalysis.
8. Enzyme nomenclature, classifications. Systematic classi-
            fication: code number, overview of classes.
Self-testing questions:
1.  Is it possible to isolate the active site in functional state
             from an enzyme structure? Explain.
2. Which is the difference between the active center of the
            simple and conjugated enzymes?
3. Name one reaction where vitamins B1, B2, B6, B12, C, PP,
            biotin, folic and panthotenic acids act as coenzymes.
4. What are the consequences of hypo- and avitaminoses?
5. Determine the class and subclass of the a-amylase and
            pepsin.
LESSON 5
Regulation of the enzyme activity.
Measures of the enzyme activity.
Factors affecting the rate of the enzyme action
Experiment 1: General properties of enzymes.
Method principle: Succinate dehydrogenase (SDH, EC
1.3.99.2) catalyzes the following oxido-reduction reaction of the
tricarboxilic acid cycle (Krebs cycle):
                                                               SDH
HOOC – CH2 – CH2 – COOH + FAD+ «
succinate
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« HOOC – CH = CH – COOH + FADH2
fumarate
FADH2 + oxidazed H+ - acceptor «    FAD+ +  reduced H+ - acceptor
    methylenazure (blue)                         methylenazure (colorless)
Procedure:
a) Enzyme specificity:
№ Reagents Test-tubes1 2 3
1 Tissue homogenate 2 ml 2 ml 2 ml
2 H2O dist 1 ml – –
3 Succinate solution, 1% – 1 ml –
4 Malate solution, 1% – – 1 ml
5 Methylenazure, 1% 3 drops 3 drops 3 drops
Incubation for 5-10 min at 38oC
Notice the colour of the solutions
Conclusion:









1. 10 drops Starch
2. 10 drops Sucrose










1. 10 drops 100o C 10 drops
2. 10 drops 38o C 10 drops




1 Tissue homogenate 2 ml 2 ml
2 Succinate solution, 1% 1 ml 1 ml
3 Malonate solution, 1% – 1 ml
4 Methylenazure, 1% 3 drops 3 drops
5 Paraffin liquid 3 drops 3 drops
6 Incubation for 5-10 min at 38o C
7 Notice the colour of the solutions
Conclusion:
e) Modification of a-amylase activity (factors affecting rate












1. 10 5 drops NaCl, 1%
2. 10 5 drops CuSO4, 1%
3. 10 5 drops H2O dist
Experiment 2: Blood serum or urinary a-amylase assay
with stabile starch substrate (Caravei method).
Method principle: a-Amylase breaks down starch to pro-
ducts (dextrines) that don't give a positive iodine reaction. a-
Amylase activity is proportional to the rate of starch break down.
Procedure:
Use graduated test-tubes (10ml).
№ Reagents Test-tubesTest Control
1 Starch solution (0,004 g/ml) 1 ml 1 ml
2 Heat the solution at 37o C 5 min –
3 Blood serum (or urine) 0,02 ml –
4 Heat the solution at 37o C 7,5 min –
5 Iodine solution 1 drop 1 drop
6 Blood serum (or urine) – 0,02 ml
7 H2O dist up to 10 ml up to 10 ml
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The extinction (optical density) of the solutions are measu-
red immediately using dest water as a comparative solution, 10
mm cuvettes and red filter (l = 630-690 nm).
Calculation: a-Amylase activity is calculated by the
formula:
A = (Ec-Et) / Ec×0,0004×8×50000 = (Ec-Et) / Ec×160 g/l×h=
Where:
Ec – extinction of the control solution
Et – extinction of the test solution
0,0004 – starch amount used for the assay
8 – the coefficient for recalculation of time to an hour of
      incubation (60 min/7,5 min = 8)
50 000 – the coefficient for the recalculation of serum or
        urine quantity to 1 liter (1000 ml/0,02 ml = 50 000)
Normal values:
in blood serum: 12-32 g/h×l
in urine: 20-160 g/h×l.
Conclusion:
Clinical–diagnostic significance: a-amylase's activity incre-
ases in blood serum and/or urine in pancreatic (acute pancreati-
tis) and parotid glands diseases.
Self-training questions:
1. Properties of the enzymes: thermolability, specificity, etc.
           Temperature and pH influence on enzyme activity and
            reaction rate.
2. Kinetics of the enzyme reactions. Enzyme-substrate com-
            plexes. Dependence of enzymic reaction rate on substrate
            and enzyme concentrations.
3. Enzymes specificity: absolute, relative, stereochemical.
4. Enzyme inhibition: competitive (isosteric), noncompetiti-
           ve, uncompetitive, allosteric, by end product
           (retroinhibition). Reversible and irreversible inhibition.
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           Therapeutical application of competitive inhibition
           (sulfanilamides).
5. Enzyme activation: proenzymes proteolysis, covalent mo-
           dification, quaternary auto-folding, allosteric.
6. Organization of multi-enzymic systems. Compartmentali-
            zation.
7. Tissue diversity of enzymes. Organospecific enzymes.
           Genetic diversity of enzymes -iso-enzymes (lactate dehy-
           drogenase, creatine kinase). Usage of enzymes and iso-
           enzymes assay in clinical diagnostics.
8. Practical utility of enzymes. Immobilized enzymes. Enzy-
            modiagnostics and enzymotherapy.
9. Purification and analysis of enzymes. Affinity chromato-
            graphy. Enzyme activity assay. Measures of enzyme
            activity (units of enzyme activity, specific activity, katal).
Self-testing questions:
1. How to prove that enzyme specificity is depended only on
            apo-enzyme?
2. How can tissue diversity of the enzymes be explained?
3. Name at least one organospecific enzyme (or iso-enzyme)
            for pancreas, liver, heart, brain and kidneys.
4. “Pancreatin” is a medicine contained enzymes of the pan-
            creatic gland. How to find out which one?
5. Which are the standart conditions for enzyme activity
            assay?
LESSON 6
Colloqium: Proteins and enzymes
1. Chemical structure and classifications of proteogenic
            amino acids.
2. Protein primary structure, the peptide bond.
3. Secondary and tertiary structures of proteins: their cova-
36
           lent and noncovalent specific bonds, conformation –
           function correlations.
4. Quaternary structure of proteins. Co-operative movement
            of protomers (on the example of hemoglobin).
5. Protein folding, conformational changes correlated with
            protein activity.
6. Proteins solubility, factors that influence it. Protein colloi
            dal solution, properties and factors for its stability.
7. Amphoteric and electro-chemical properties of proteins.
            Isoelectric state and point.
8. Protein coagulation and precipitation in solution. Salting-
            out.
9. Denaturation (denativation) and renaturation (renativati-
            on) of proteins.
10. Proteins classification. Simple and complex (conjuga-
               ted) proteins. Characteristics and functions of proteins.
11. Collagen: peculiarities of amino acid composition, struc-
               ture and properties.
12. Enzymes. Classifications and nomenclature of enzy-
               mes. Functions of the enzyme.
13. Structural and functional organization of enzymes.
              Active and allosteric sites, nature and role. Notions of
              substrate and allosteric modulator (effector).
14. Simple and complex enzymes. Notions of cofactor, co-
               enzyme and prosthetic group.
15. Water-soluble vitamins as coenzymes. Structure and
               metabolic function of vitamins B1, B2, B6, PP, C, biotin,
               folic and pantothenic acids.
16. Provitamins and antivitamins: notions, examples and
               role. Utility in medicine (sulphanilamides, etc.).
17. Mechanism of enzymic action, enzyme kinetics. Influ-
               ence of temperature, pH, substrate and enzyme
               concentrations on the reaction rate.
18. Regulation of enzyme activity. Activation and inhibiti-
              on types. Enzyme activation: partial proteolysis,
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               quaternary auto-folding, covalent modification,
               allosteric mechanism.
19. Inhibition of enzyme activity: competitive (isosteric),
               noncompetitive and allosteric inhibition. Medical utility
               of competitive inhibitors.
20. Enzymes specificity: types, characterictics and exam-
               ples.
21. Genetic diversity of enzymes. Multiple molecular forms
               of enzymes (isoenzymes), examples. Use of isoenzymes
               assay in diagnostics (LDH, CPK, etc.).
22. Methods of enzyme separation and purification. Affini-
               ty chromatography.
23. Practical utility of enzymes: immobilized enzymes, en-
               zymodiagnostics and enzymotherapy.
24. Enzyme’s activity assay. Units of enzyme activity.
25. Biochemical adaptation. Enzyme induction and repres-
               sion, inductive and constitutive enzymes.
CHAPTER III
Nucleic acids: structure and biosynthesis.
Protein biosynthesis and its regulation
There are two types of nucleic acids in the human organism:
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Nucle-
ic acids are polymers-polynucleotides. Monomeric unit is a nu-
cleotide including three components: nitrogenous base (adenine,
guanine, cytosine, thymine, uracil), pentose (ribose, deoxyribo-
se), phosphate. The nucleotides are linked in polynucleotides
through 3’,5’-phosphodiester bonds. Four nucleotides in the po-
lynucleotide chains are specific for each type of nucleic acid: A,
T, G, C for DNA and A, U, G, C for RNA. Both DNA and RNA
have a characteristic conformation that evolves from the primary
structure to a nucleoproteic complex.
DNA is the carrier of genetic information (genome) in all or-
ganisms except certain viruses (e.g. tobacco mosaic virus, polio-
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virus, influenza virus), which use RNA for this purpose. The bio-
synthesis of either DNA or RNA, where the parental nucleic acid
serves as a template to direct the structure of the product, is
named replication. Transcription (synthesis of RNA) means the
transport of genetic information from DNA to RNA, and reverse
transcription means the reverse process (from RNA to DNA).
When  DNA  is  transcribed  into  RNA,  three  different  kinds  of
RNA can be identified: messenger RNA (mRNA), transfer RNA
(tRNA) and ribosomal RNA (rRNA). Replication and transcrip-
tion are important sites for the action of drugs, either to protect
eukariotic cells from action of bacteria and viruses or to inhibit
the growth of neoplasic cells. Changes in base sequence of DNA
are called mutations. There are several kinds of mutations: sub-
stitutions (transition and transversion), deletion, insertion. Muta-
tions can be spontaneous, can arise from DNA polymerase mal-
function and can be induced by mutagens. Mutations can be
repaired or can evolve in genetic diseases.
Translation (synthesis of protein) means the transport of ge-
netic information from mRNA to the polypeptide chain, the
mRNA serving as a template which directs the primary structure
of the polypeptide. The code for the translation of the sequence
of four different nucleotides in mRNA into the order of the 20
amino acids in a polypeptide is known as genetic code. The cod
is triplet, degenerate, universal and collinear. It has chain start
and termination signals and, also, reading frames. Post-translati-
onal modification takes place after termination of polypeptide
chain synthesis.
LESSON 7
Structure of nucleic acids.
Biosynthesis of DNA (replication)
Experiment 1. Protein identification (Biuret reaction).
Mix 5 drops of hydrolysate, 10 drops  of 10% NaOH, and 2
drops of 1% CuSO4.
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Conclusion:
Experiment 2. Pentose identification (Molisch reaction).
Method principle: H2SO4 turns ribose in furfurole which
condense with thymol to a purpule complex compound.
Procedure:
Mix 10 drops of hydrolysate and 3 drops of alcoholic thymol
solution, 1%. Shake the mixture, bend the test-tube and add 20-
30 drops of concentrated H2SO4.
Conclusion:
Experiment 3. Molybdenum reaction for phosphoric acid
identification.
Method principle: When phosphoric acid is treated with mo-
lybdenum reagent the yellow sediment is produced.
Procedure:
Mix 10 drops of hydrolysate and 20 drops of molybdenum
reagent. Boil the mixture, and cool it in flowing water.
Conclusion:
Experiment 4. Ribose and deoxyribose identification
(diphenylamine reaction).
Method principle: When ribose is created with diphenylamine a
green colour is produced, while deoxyribose gives a blue colour.
Procedure:
5 drops of hydrolysate are mixed with 20 drops of dipheny-
lamine solution, 1%. The mixture is boiled for 15 minutes.
Conclusion:
Self-preparing questions:
1. Nucleic acids: types, functions and intracellular location.
2. Nucleic acid's components: nitrogenous bases, pentoses,
            phosphate.
3. Nucleosides, nucleotides, cyclic nucleotides: structure,
            functions. Usage of nucleotides and natural or synthetic
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            analogs in therapy.
4. Primary, secondary and tertiary structures of DNA. Nuc-
            leosomes. Chromosomes.
5. RNA structure. Peculiarities of tRNA, mRNA, rRNA
            structure.
6. Denaturation and hybridization of nucleic acids, utility in
            medicine.
7. Structure of the genes (introns, exons).
8. The central dogma of genetics. Genetic code and its cha-
            racteristics.
9. Replication (duplication) of DNA: template, enzymes,
            substrates. Telomeres and telomerases, biological role in
            the cells.
Self-testing questions:
1. Write the formulas: a) adenine, adenosine, adenylic acid,
            adenosine triphosphate; b) thymine, thymidine,
            thymidylic acid, thymidine triphosphate.
2. Write the structure of the tetranucleotides: a) 5'–ATGC-
            3' ; b) 5' – UGCA - 3'.
3. Find the difference between the dinucleotides of a nucleic
            acid and of a nucleotidic coenzyme (NAD).
4. Name all types of bonds that stabilize nucleic acid's struc-
            ture.
5. Estimate how many pairs of nucleotides are in: a) 1 mm of
            the DNA double helix; b) 1 mln Da of the DNA double
            helix.
6. The content of adenine in the DNA of two unidentified
            types of bacteria is correspondingly 32% and 17%.
           Which is the amount of guanine, cytosine and thymine in
           each one? Which DNA belongs to the bacteria that were
           discovered in a thermal spring? Explain.
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LESSON 8
Biosynthesis of nucleic acids.
Genes: mutations, repair of DNA
Experiment 1: Quantitative analysis of DNA.
Method principle: When DNA is treated with diphenylamine
deoxyribose interacts with the reagent to produce a blue-coloured
compex. The intensity of the coloration is proportional to the
DNA quantity.
Procedure:
№ Reagents Test-tubesTest Control
1 Yeast hydrolysate 1 ml –
2 H2O dist – 1ml
3 Diphenylamine reagent 2 ml 2 ml
4 Boil the test-tubes for 10 minutes
5 Cool the solutions in a water flow
6 Extinction of the test solution is measured in comparison with
the control solution, using 5 mm cuvettes and red filter (l=630-
690 nm). DNA quantity is estimated using the calibration
graph.
Calculation:  E =             C =
Experiment 2: Quantitative analysis of RNA.
Method principle: When RNA is treated with orcinol reagent
(orcinol ferric choride reagent, Bial’s reagent) ribose interacts
with the reagent to produce a green-coloured complex. The in-
tensity of the coloration is proportionate to the quantity of RNA.
Procedure:
№ Reagents Test-tubesTest Control
1 Yeast hydrolysates 1 ml –
2 Orcinol reagent 1 ml 1 ml
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3 H2O dist – 1 ml
4 Boil the test-tubes for 20 minutes
5 Cool the solutions in a water flow
6 Extinction of the test solution is measured  in comparison with
the control solution, using 5 mm cuvettes and red filter (l=630-
690 nm). RNA quantity is estimated using the calibration graph.
Calculation:  E =               C =
Self-preparing questions:
1. Transcription or RNA biosynthesis: the template, substra
            tes, enzymes, mechanism.
2. Post-transcriptional alterations (modifications) of the
          RNA. Maturation of pre-mRNA, pre-tRNA and pre-rRNA.
3. Reverse transcription, mechanism.
4. Molecular mutations: mutagens, role of mutations.
5. Reparation of DNA, mechanism.
6. Inhibitors of nucleic acids synthesis. Antibiotics: chemi-
           cal structure, mechanism of antibiotics and
           antimetabolites action that influence on replication and
           transcription; action of antibiotics on the level of bacteria
           cell membrane.
7. Genetic engineering. Its means for synthesis of the natural
            preparations (drugs).
Self-testing questions:
1. What enzymes and compounds are necessary for the syn-
            thesis of the:
a) leading strand;
b) lagging strand of DNA?
2. Which will be the composition of the new-DNA synthesi-
            zed by DNA-polymerase using as a template single-
            strand DNA of the bacteriophage 174? It contains: G-
            24,1%, C-18,5%, A-24,6%, T-32%.
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3. Which is the composition of the DNA that was synthesi-
            zed on the DNA template of the bacteriophage 174 ((+)
            and (-) strands)?
4. What factors are ensured the exactness of replication?
5. Is the lagging strand synthesized with the same exactness
            as the leading one?
LESSON 9
Protein biosynthesis and its regulation.
Biosynthesis of antibodies
Experiment 1: Quantitative assay of blood serum
proteins (Biuret method).
Method principle: The assay is based on biuret reaction.
Procedure:
№ Reagents Test-tubesTest Control
1 Blood serum 0,1 ml -
2 H2O dist - 0,1 ml
3 Biuret reagent 4,9 ml 4,9 ml
4 Incubation for 30 min at the room temperature
5 The extinction of the experimental solution is measured in
comparison with the control solution using 10mm cuvettes and
green filter (l=540-560 nm). Protein quantity is estimated using
the calibration graph.
Normal values:  C= 65 - 85 g/l.
Calculation:  E =              C =
Conclusion:
Clinical-diagnostic significance: Protein content in the
blood serum decreases (hypoproteinemia) in nephrites, cirrhosis,
starvation, hemorrhage, etc. Increased protein content in the
blood serum is called hyperproteinemia and is specific in




1. Ribosomes: composition, structure.
2. Protein synthesis:




e) post-synthetic changes of proteins (post-translational
                  modifications).
3. Regulation of protein biosynthesis. Enzyme induction and
            repression (lactose operone).
4. Preparations affecting protein biosynthesis: activators and
            inhibitors. Protein synthesis inhibitors. Antibiotics:
            inhibitors of translation, mechanism of action.
5. Structure and peculiarity of antibodies production, antibo-
            dies usage as medicines in therapy.
6. Proteins diversity (hemoglobin, antibodies and enzyme
            isoforms).
7. Inherited disorders and their clinico-biochemical diagno-
            stics.
Self-testing questions:
1. What difference is there between RNA-polymerase and
            polynucleotide-phosphorylase?
2. (+) Single-stranded DNA (A-21%, G-29%, T-21%, C-
            29%) is replicated by DNA-polymerase to form the (-)
            strand. The (-) strand is served as a template for RNA-
            polymerase. Which will be the RNA composition?
3. Bacteriophage 174 DNA contains the 5386 nucleotides.
           This amount is not enough to encode all the proteins that
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               are synthesized by it. How to explain this phenomenon?
CHAPTER IV.
METABOLISM. BIOENERGETICS
The vital activity of any living organism is determined by
the specific organization of biological structures, metabolic pro-
cesses, energy metabolism, genetic information transfer, and re-
gulatory mechanism. Damage of any of these links develops a
pathological process and a disease in the organism.
In the overall metabolism of the living organism are distin-
guished: exogenous metabolism, which comprises extracellular
transformations of materials on the way to their uptake and ex-
cretion by the cells, and intermediary metabolism, which occurs
in the cells. The intermediary metabolism is conceived as the
sum of chemical reactions that occur in the living cell.
The sequences of chemical reactions involved form metabo-
lic pathways, or cycles, each of these performing a definite func-
tion. Conventionally, central and special metabolic pathways are
distinguished.
In the metabolism, two oppositely directed processes, or
phases, are commonly distinguished: catabolism and anabolism.
Catabolism is  the  sum  of  degradative  processes  leading  to  the
cleavage of large molecules into smaller ones. Anabolism is the
sum of metabolic processes leading to the synthesis of complex
molecules from simpler ones. Catabolism is accompanied by a
release of energy that can be stored as energy-rich ATP. Anabo-
lic processes proceed through consumption of ATP and decom-
position of the latter into ADP and H3PO4.
The biological activity of the cell is closely associated with
the continuous redistribution of the energy delivered by the com-
pounds that enter the cell. The storage of energy in the specific
phosphate bonds of ATP constitutes the basis for the energy tran-
sfer mechanism in the living cell. The energy resources stored in
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the cells are used to provide for the cells energetic requirements.
They include monosaccharides, amino acids, glycerol, fatty acids.
In the process of energy release from various substrates,
three conventional stages may be defined. The first stage is nece-
sary for converting biopolimers to a monomeric form suitable for
energy extraction. The second stage is partial degradation of
monomers to key intermediates, chiefly to acetyl-CoA and to a
number  of  the  Krebs  cycle  acids.  The  third  stage  represents  an
ultimate, oxygen-assisted degradation of the materials to CO2
and H2O. This phase comprises the aerobic biological oxidation
of materials and proceeds with a complete release of energy
(ATP).
LESSON 10
Introduction to metabolism. Bioenergetics. Oxidative
decarboxylation of pyruvate to acetyl-SCoA.
The tricarboxylic acid cycle (Krebs cycle)
Experiment 1: Quantitative assay of pyruvate in urine.
Method principle: When pyruvate is treated with 2,4-
dinitrophenylhydrazine in alkaline conditions a yellow-orange
complex is produced.
Procedure:
№ Reagents Test-tubesTest Control
1 Urine 1 ml –
2 H2O dist – 1ml
3 2,5% alcoholic solution 1 ml 1 ml
4 Shake thoroughly for 60 seconds
5 Dinitrophenylhydrazine solution, 0,1% 0,5 ml 0,5 ml
6 Shake thoroughly and incubate it for 15 minutes at room
temperature
47
7 Extinction of the experimental solution is measured in compa-
rison with the control solution using 5 mm cuvettes and blue
filter. The pyruvate content is estimated by the calibration
graph.
Normal values: 113,7-283,9 mM/24 hours
                          (10-25 mg/24 hours).
Clinical-diagnostic significance. Pyruvate content rises in B1
deficiency, diabetes mellitus, hyperfunction of hypophysis
(pituitary) and/or adrenal glands, introduction of adrenalin,
camphor or strychnine.
Results: E =                      C =
Conclusion:
Self-preparing questions
1. Introduction to metabolism. Catabolism and anabolism.
           The final common metabolic pathway. Central, cyclic and
           specific metabolic pathways.
2. Metabolism assay: approaches and methods.
3. Free energy, the standard state. High-energy compounds:
            structure and functions. ATP-cycle.
4. The energetic state of the cell. Energetic regulation of
            metabolism.
5. Oxidative decarboxylation of pyruvate to acetyl-CoA:
            multienzyme complex, coenzymes, reactions, control.
6. The tricarboxylic acid cycle (Krebs cycle): reactions,
            functions, stoichiometry, control. The biological role of
            the Krebs cycle. Substrate phosphorylation. Energy
            balance of the Krebs cycle.
7.  Anaplerotic reactions for the Krebs cycle.
Self-testing questions
1. Write the chemical structure of vitamins and their coen
            zymes:
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a) B1 and TDP (TPP);
b) B2 and FMN;
c) B5, nicotinamide and NAD.
2. Why does NADH+ (NADH2) solution have the acidic me
            dium (pH<7.0)?
LESSON 11
Mitochondria electron transport chain. Oxidative
phosphorylation
Experiment 1: Qualitative analysis of catalase activity.
Method principle: Catalase catalyzes the reaction:
                       2 H2O2 ® 2 H2O + O2­.
Procedure
№ Reagents Test-tubesTest Control
1 H2O dist 1 ml 1 ml
2 Blood 2 drops 2 drops
3 Incubation for 1-2 min 37oC 100oC
4 H2O2, 1% 5-10 drops 5-10 drops
6 Shake thoroughly
7 Gas elimination (O2)
Conclusion:
Experiment 2: Quantitative analysis of catalase activity.
Method principle: Catalase activity is estimated by H2O2
amount that is broken down in a time unit. The H2O2 quantity is
evaluated from the reaction:
2 KMnO4 + 5H2O2 + 4H2SO4 ® 2 KHSO4 + 2 MnSO4 + 8 H2O + 5 O2
The catalase activity is expressed in conventional units. A




Dilute the blood to 1:1000. Shake thoroughly the solution.
№ Reagents FlasksTest Control
1 blood (1:1000) 1 ml 1 ml
2 H2O dist. 7 ml 7 ml
3 H2O2, 1% 2 ml –
4 H2SO4, 10% – 5 ml
5 Incubate 30 minutes at room temperature
6 H2SO4, 10% 5 ml –
7 H2O2, 1% – 2 ml
8 Titrate both solutions with 0,1N KMnO4 to pink color
Calculation: the activity of catalase is calculated by the
formula:
CU = (A-B)×1,7=                  where:
A - quantity of KMnO4 used for titration of the control
       solution.
B - quantity of KMnO4 used for titration of the test solution.
Normal values: 10 - 15 units.
Clinical-diagnostic significance.  The  activity  of  catalase
decreases in cancer, anemia, tuberculosis, etc.
Results: A =           B =                 CU= (A-B)×1,7=
Conclusion:
Self-preparing questions
1. Biological oxidation. Dehydrogenases. Dehydrogenation
            – energy source for ATP biosynthesis.
2. Mitochondria electron transport chain (ETC), or respira-
            tory chain (RC): organization, enzymic complexes.
            Electrons and protons acceptors, structure, function.
3. Reduction-oxidation (redox) potential of ETC componen-
            ts. Free energy and sites of ETC for ATP production
            (oxidative phosphorylation).
4. The ATP:O or P:O ratio. Respiratory control. Free respi
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            ration.
5. Mitochondria: structure, properties, permeability for dif-
            ferent compounds. The glycerol-3-phosphate and malate-
            aspartate shuttle systems.
6. Mechanism of oxidative phosphorylation: chemiosmotic
            hypothesis (Mitchell hypothesis).
7. Microsomal oxidation: electron transport chains, cyto-
            chrome P450 function and role in inactivation of
            xenobiotics and drugs.
8. Oxygen free radicals, free radical oxidation. Lipid peroxi-
           dation of the cell membranes. Antioxidative systems
           defense of the human organism.
Self-testing questions
1. What is the proton potential or H+ electrochemical gradi-
            ent?
2. What are the short, middle or long types of Respiratory
            chain?
3. What do you know about the biorole of cytochrome oxi-
            dase? Write the reaction with its participation.
4. Where is the site of rotenone (fish poison) inhibition of
            the Respiratory chain?
5. Name the respiration inhibitors of cytochrome oxidase.
6. Write the reaction catalyzing of H+-ATPase.
7. Please, calculate the coefficients P/O values for isocitrate




1. Metabolism. Anabolism and catabolism. Metabolic path-
            ways: central and specific, cyclic and linear, amphibolic.
2. Stages of anabolism and catabolism. The common path-
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           way of catabolism and anabolism, its role. Connections of
           anabolism and catabolism.
3. High-energy phosphate compounds: chemical structure,
            properties and functions. The ATP cycle. The ways of
           ATP biosynthesis and utilization.
4. Free energy, standard free energy. Exergonic and ender-
            gonic reactions. Coupled reactions.
5. Biological oxidation. Reduction-oxidation reactions. Red-
           ox-potential.
6. Oxidative decarboxylation of pyruvic acid: location, mul-
            tienzymic complex, coenzymes, reactions, connection
            with the Krebs cycle and respiratory chain (RC).
            Energetic output (balance) of pyruvic acid oxidation.
7. The Krebs cycle: reactions, enzymes, regulation. Anaple-
            rotic reactions, role, examples. Energetic output (balance)
            of the acetyl-CoA oxidation in tricarboxylic acid cycle
            (Krebs cycle). Interrelation with RC.
8. Mitochondria electron transport chain (ETC or RC): loca-
            lization, structure and function of its components. Their
            oxidized and reduced states.
9. Sources of protons and electrons. Dehydrogenation reacti-
            ons: the main energy sources in the human cells. NAD-
            and FAD-dependent dehydrogenases, their connection
            with the RC.
10. Mechanism of protons and electrons transport through
               the respiratory chain. Long, media and short ways of
               electron transport: sources of electrons for RC and ATP
               production.
11.  Redox-potential. ATP production (oxidative phospho-
                rylation). RC sites of   phosphorylation, the P/O ratio.
                Inter-relation of oxidation (respiration) and
                phosphorylation.
12. ATP-synthetase, structure and function. Mechanism of
               oxidative phosphorylation: chemiosmotic coupling
               Mitchell hypothesis.
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13. Regulation of respiratory chain function: inhibitors of
               electrons transport, uncouples of oxidative
               phosphorylation and phosphorylation inhibitors, role,
               examples and consequences of their influence.
14. Chemical structure of vitamins and vitamin-like com-
              pounds of the respiratory chain (PP, B2, ubiquinone).
              Notion about chemical structure of cytochromes (b, c,
              a), their role, oxidized and reduced state.
15. Glycerol-3-phosphate and malate-aspartate shuttle sys-
               tems: role, intracellular location, reactions, enzymes
               and connection with RC.
16. Microsomal electron transport chains (monooxigenase
               and reductase): structure, functions and location.
               Cytochrom P450, role in inactivation of xenobiotics,
               drugs.
17. Oxygen toxicity. Oxygen free radicals: mechanism of
               formation and toxicity. Lipid peroxidation.
               Antioxidative defense systems: enzymes, non-enzymic
               compounds.
CHAPTER V
Carbohydrates structure and metabolism
Carbohydrates are polyhydroxy aldehydes, polyhydroxy ke-
tones, or compounds that can be hydrolyzed to them. Monosac-
charides are simple sugars which cannot be broken down into
smaller molecules by hydrolysis (glucose, fructose, ribose, etc.).
Their nomenclature indicates the number of carbons (triose, te-
trose, pentose, hexose, etc.) or the reactive groups (aldoses and
ketoses). Disaccharides (sucrose, maltose, lactose) can be hydro-
lyzed into two monosaccharides (glucose, galactose). Oligosac-
charides are polymers made up of two to ten monosaccharide
units. Polysaccharides are polymers with many monosaccharide
units (amylose, amylopectin, starch, glycogen and cellulose).
Carbohydrates have a number of derivatives: phosphoric acid
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esters, amino sugars, sugar acids, deoxysugars, etc. Carbohydra-
tes may be considered as having two distinct and vital functions.
First – as substrates which oxidation provides energy for biosyn-
thetic reactions and work; second – as structural compounds.
Glucose is of special importance as an energy source. It acts
as a substrate for glycolysis, one of the main energy-rich oxidati-
ve pathways. Glucose derived from the energy-storage polymers-
starch, in plants, and liver are major sites for the storage of gly-
cogen. The glycogen stores allow us to eat intermittently by pro-
visional an immediate source of blood glucose for use as a meta-
bolic fuel. During starvation or during periods of limited carbo-
hydrate intake, when the levels of liver glycogen are low, gluco-
neogenesis maintains adequate blood sugar concentrations.
 Several alternate pathways of carbohydrate metabolism
serve as sourse of compounds for synthesis or detoxication:
pentose phospate pathway, uronic acid pathway, fructose and
lactose metabolism.
Insulin and glucagon are the major regulators of carbohydra-
tes metabolism. Also, the important role play adrenalin, gluco-
corticoids and thyroid hormones.
LESSON 13
Carbohydrate chemistry. Carbohydrate digestion and
absorption. Glycogen metabolism.
Aerobic and anaerobic pathways of glycolysis.
Experiment 1: Trommer reaction.
Method principle: When monosaccharides are treated with
Cu(OH)2 in  alkaline  solution,  a  brick-red  precipitate  of  Cu2O is
formed.
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CuSO4 + 2NaOH ® Na2SO4 + Cu(OH)2
blue
Glucose + 2Cu(OH)2 ® gluconic acid + H2O + 2CuOH
yellow
2CuOH ® H2O + Cu2O
brick-red
Procedure:
№ Reagents Test-tubesI II III IV
1 Glucose 1 ml – – –
2 Sucrose – 1 ml – –
3 Starch – – 1ml –
4 Urine – – – 1 ml
5 NaOH, 10% 1 ml 1 ml 1 ml 1 ml
6 CuSO4,2%, the blue colour the solution 0.2 ml 0.2 ml 0,2 ml 0.2 ml
7 Heat carefully the mixtures, to =100o C (2 min)
8 The colour of the solution
Сonclusion:
Experiment 2: Fehling reaction.
Method principle: It is the same as in experiment 1.
Procedure:
№ Reagents Test-tubesI II III IV
1 Glucose 1 ml – – –
2 Sucrose – 1 ml – –
3 Starch – – 1ml –
4 Urine – – – 1 ml
5 Fehling solution 1 ml 1 ml 1 ml 1 ml
6 Boil the mixtures (2 min)
7 The colour of the solution
Сonclusion:
Experiment 3: Seliwanoff's reaction.
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Method principle: When  ketose  (fructose)  is  heated  with
HCl and resorcinol, the solution colour turned to cherry-red.
Procedure:
№ Reagents Test-tubesI II
1 Seliwanoff's reagent 1 ml 1 ml
2 Glucose solution 2 drops –
3 Fructose solution – 2 drops
4 Heat the mixtures  (to=100oC, 2 min)
5 Colour of the solution
Conclusion:
Experiment 4: Salivary a-amylase activity assay
(Wolghemuth's method).
Method principle: Method is  based  on  the  determination  of
the minimum quantity of a-amylase which hydrolyzes the added
starch completely.
Procedure: Dilute saliva 1:10 (1 ml saliva + 9ml H2O dest).
Put 1 ml of distilled water in six test-tubes. Add 1 ml of saliva to
the water in the 1st test-tube and mix thoroughly. After that, 1 ml
of mixture transfer from the 1st test-tube to the 2nd one. Mix the
content of the 2nd test-tube  and  repeat  the  procedures  to  the  6th
test-tube.  Mix  the  solution  of  the  6th test-tube and take away
(remove) 1 ml from it.
Put in every test-tube 2 ml of starch solution, 0,1%, mix and
put them in a bath (38oC) for 30 min. Cool the test-tubes with so-
lutions in a cold water flow. After that put 1 drop of iodine solu-
tion, 0,1%,  in each test-tube, mix the solutions and note their co-
lour.
Calculation: Note the test-tube with the lowest amount of a-
amylase which completely hydrolyzed the starch. Knowing the
dilution calculate the activity of a-amylase using the ratio:
1 ml of diluted saliva breaks up 2 ml of starch solution, 0,1%;
1 ml of undiluted saliva breaks up X ml of starch solution, 0,1%.
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         2 × 1
X = ------- = 2:a =          where: a – dilution of the saliva in the
         1 × (a)                    test-tube, where the starch was
                                      completely hydrolyzed
Note: Dilutions of the solutions are the following:
№ 1 2 3 4 5 6
Dilution (a) 1:20 1:40 1:80 1:160 1:320 1:640
Conclusion:
Self-preparing questions
1. Carbohydrate definition, physiologic importance and
classification.
2. Monosaccharides, disaccharides, polysaccharides:  struc-
            ture, properties and functions.
3. Glucosamine glycans (heteropolysaccharides): hyaluronic
            acid, chondroitin sulphates, heparin, structure and
            functions in organism.
4. Digestion and absorption of carbohydrates.
5. Glycogen metabolism: glycogenogenesis and glycolgeno-
            lysis pathways, regulation.
6. Glycolysis: aerobic and anaerobic pathways. The aerobic
            pathway of glycolysis.
7. Anaerobic glycolysis in tissues. The enzymatic reactions
           of glycolysis anaerobic pathway. Stoichiometry of this
           process.
8. Regulation of glycolysis: hormonal regulation, mechanisms.
9. Energy balance of aerobic and anaerobic degradation of
            glucose.
10. Mechanisms for translocation of NADH+ from cytosol
              into mitochondria matrix: a-glycerophosphate and
              malate-aspartate shuttle systems.
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Self-testing questions
1. Write the structural features of b,D-glucopyranose, b,D-
             fructofuranose, N-acetyl-glucosamine.
2. Write the chemical structure of sucrose, lactose.
3. Write the linear disaccharides formed by D-glucose units
            linked through a-(1-4)-glycoside bonds.
4. Cellulose: its chemical structure and properties.
5. Write the exergonic reactions of glycolysis.
6. Write the endergonic reactions of glycolysis.
7. Why is the 1,3-biphosphoglycerate an energy-rich com-
            pound?
8. Name the enzymes of glycolysis: oxido-reductases, iso
            merases, lyases.
9. Write the reaction of alcoholic fermentation of lactate.
10. What is energy balance (ATP production) of glycoly-
              sis?
LESSON 14
Alcoholic fermentation. Glyconeogenesis.
 Oxidation of fructose and galactose.
 Pentose-phosphate pathway
Experiment 1: Inorganic phosphate consumption in alco-
holic fermentation.
Method principle: Inorganic phosphate is used in the forma-
tion of 1,3-diphosphoglycerate during the alcoholic fermentation
of glucose. Thus its content in the solution decreases.
Procedure:
Step 1. Use 4 test-tubes. Put 1 ml of tricloracetic acid, 10%,
in each one, 1 g of yeast and 1 g of glucose (or sucrose) triturate,
then add 5 ml of phosphate solution. Shake the mixture and im-
mediatly transfer 1 ml of it  into the 1st test-tube. Put the rest of
the mixture into a bath with toC=37oC. Every 30 min transfer 1
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ml of mixture into the next numbered test-tube. These solutions
filtrate and use for phosphate determination.
Step 2. Put 0,5 ml of each filtrate into numbered test-tubes.
After that add 1 ml of molybdenic reagent, 0,5 ml solution of vi-
tamin  C  and  8  ml  H2O dest. The intensity of the coloured
solutions is compared in 15 min.
Conclusion: Explain the differences of colour.
Experiment 2: Determination of glucose in blood (O-to-
luidinic method).
Method principle: Glucose with solution of acetic acid at
boiling composes the green-coloured complex. Between glucose
concentration and intensity of coloured complex there is a direct
correlation.
Procedure:
№ Reagents Test-tubesTest Standard
1 Blood 0,1 ml –
2 Standard (glucose, C=5 mM/l) – 0,1 ml
3 TCA, 3% 0,9 ml 0,9 ml
Centrifugation at 3 000 /min for 10 min
4 Supernatant 0,5 ml 0,5 ml
5 O-toluidine solution 4,5 ml 4,5 ml
Incubation: 8 min at to=100o C
Determine the extinction (E) of the test and standard solutions
using 5 mm cuvettes, red filter, water for comparison.
Calculation: Ct= Cst Et/Est =               mmol/l.
Norma: 3,33 - 5,55 mmol/l.
Conclusion:
Clinico-diagnostical means: Hyperglycemia: diabetes melli-
tus, steroid diabetes, acute pancreatitis, etc. Hypoglycemia: hy-
pofunction of thyroid gland, hypofunction of adrenal glands, de-
ficiency of glucose absorbtion or reabsorbtion.
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Self-preparing questions
1. Metabolism of fructose and galactose.
2. Alcoholic fermentation of glucose. Production of energy.
3. Pentose-phosphate pathway of glucose oxidation: locati-
            on, biological role. Chemical reactions of apotomic cycle.
4. Gluconeogenesis: energetically irreversible chemical reac-
             tions (steps) of glycolysis,  pathway, substrates, regulation.
5. Gluconeogenesis, usage of lactate for this process. Gluco-
            se-lactate cycle (Cori cycle) and glucose-alanine cycle, its
            biological role.
6. Amino acids as substrates for gluconeogenesis.
Self-testing questions
1. Name all vitamins of the pyruvate dehydrogenase com-
            plex (PDH-complex).
2. Why is malonate of the Krebs cycle inhibitor? Where is
             the site for its action?






4. Calculate the number of ATP molecules produced during
            oxidation of one molecule of lactate in aerobic
            conditions.
5. How many molecules of ATP will be produced in aerobic
            conditions of glutamic acid oxidation?
6. Write the reaction which is catalized by glucose-6-phos-
            phate dehydrogenase (G6PDH).
7. Why is the phosphogluconate pathway also called hexose
            monophosphate shunt?
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LESSON 15
Regulation and pathology of carbohydrate metabolism
Self-preparing questions:
1. Carbohydrate metabolism regulation in cells, organs and
            the whole organism.
2. Assay of the glycoregulatory function of the organism
            (hyperglycemic tests and functional galactose test).
3. Disorders of the carbohydrate metabolism:
a) hyperglycemia, hypoglycemia and glucosuria;
b) diabetes mellitus (types I and II), metabolic disorders.
                  Mechanism of insulin action.
c) steroid diabetes.
d) inborn deseases: fructose intolerance, galactosemia,
                  lactose intolerance, glycogenoses and aglycogenoses.
e) disorders of glucose metabolism in hypoxia.
4. Principle and methods of glucose determination in the
            blood.
Self-testing questions
1. Mechanism of insulin action (name the right answer):
a) breakdown of glycogen in glucose;
b) transport of glucose from the blood to tissues;
c) activation of the Na+,K+-pump;
d) insulin increases the cell membrane penetration for
                  amino acids and fatty acids.
2. Processes leading to hypoglycemia:
a) transport of glucose from blood to tissues;
b) glycogen synthesis from glucose in the liver and ske-
                  letal muscles;
c) absorption of glucose from the intestine;
d) production of triacylglycerol from glucose in fat tis
                  sue;
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e) gluconeogenesis (in liver and kidney).
3. Which hormones do you know that are increased of glu








1. Carbohydrates: functions, classifications and nomenclatu-
             re.
2. Chemical structures of monosaccharides, disaccharides
            (maltose, lactose, sucrose) and polysaccharides (starch,
            glycogen).
3. Glucosamine glycans (heteropolysaccharides): hyaluronic
            acid, chondroitin sulphates, heparin, structure and
            functions in organism.
4. Digestion and absorption of carbohydrates in the gastro-
            intestinal tract.
5. Glycogen synthesis (glycogenogenesis): role, major tissue
            sites, reactions, enzymes, regulation.
6. Glycogen mobilization (glycogenolysis): role, reactions,
            enzymes and regulation.
7. Aerobic and anaerobic pathways of glycolysis: enzymatic
            reactions of glycolytic anaerobic pathway, regulation,
            substrate phosphorylation. Energy balance of glycolysis.
8. The aerobic pathway of glycolysis: partial reactions to
            pyruvate, end products, energy balance.
9. Mechanisms for translocation of H+ and electrons from
            cytosol into mitochondria matrix: a-glycerophosphate
            and malate-aspartate shuttle systems. Glycolytic reactions
            of dehydrogenation, their link with the respiratory chain.
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10.  Gluconeogenesis: definition, functions, tissue location,
                partial reactions, energetic expenses. Gluconeogenesis
                (from pyruvate): reactions, enzymes, regulation.
11. The glucose-lactate cycle (Cori cycle) and glucose-ala-
               nine cycle, description and biologic role.
12. Neuro-hormonal regulation of the blood glucose con-
               centration in the health organism: insulin, glucagon,
               glucocorticoid influence.
13. Disorders of carbohydrate metabolism: hyperglycemia,
               hypoglycemia, glucosuria. The glucose tolerance tests.
14. The pentose phosphate pathway: partial reactions, regu-
               lation, biological role.
15. The metabolism of fructose and galactose in liver and
               muscles.
16. Alcohol fermentation: reactions, energetic output, signi-
               ficance.
17. Diabetes mellitus, steroid diabetes: types, metabolic di-
               sorders and consequences. Mechanism of
               hyperglycemia, glucosuria, ketonemia and ketonuria in
              diabetes mellitus.
CHAPTER VI
Lipids chemistry and metabolism
Lipids are compounds which are insoluble in water and rea-
dily soluble in nonpolar solvents such as ether, chloroform, ben-
zene, etc. Lipids are generally esters of fatty acids and alcohol.
Lipids  serve  as  storage  and  transport  forms  of  metabolic  fuel,
provide structural components of cell membranes, have protecti-
ve  functions  serving  as  a  part  of  the  outer  coating  between  the
body and the enviroment.
Lipids  classifications  are  based  on  their  chemical  structure,
physico-chemical properties and functions. There are monomers
of lipids (fatty acids, superior alcohols and aminoalcohols, iso-
prene derivatives) and polycomponent lipids. The last class has
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two subclasses: simple and complex polycomponent lipids. Sim-
ple polycomponent lipids are esters of alcohol and fatty acids
(waxes, acylglycerols).
The complex polycomponent lipids have in their structure
additional compounds: phosphoric acid (phosphoglycerides),
sphingosine (sphingomyelin), mono- or oligosuccharides (glyco-
lipids).
There are three main forms of lipids in the organism:
a) protoplasmic lipids are structural components of the
                  cell membranes;
b) reserve lipids are concentrated in adipose tissue and
                  serve as metabolic fuel;
c) plasmic lipoproteins are the forms of lipid transport in
                  the blood.
Among the tissues of the organism, the structural lipids are
distributed nonuniformly. The nerve tissue is the richest one in
structural lipids (to 20-25%). In biomembranes of the cell the li-
pids make up about 40% (dry weight).
The daily requirement for lipids is 80 g, both of animal and
vegetarian origin. An adequate diet includes fat-soluble vitamins
(A, D, E, K) and essential fatty acids (linoleic and linolenic aci-
ds). Digestion and absorption of lipids are complex and require
bile, pancreatic juice and lipolytic enzymes.
The bile acids and their salts:
a) act as detergents and contribuite to the emulsification
                  of lipids,
b) activate lipid-specific enzymes,
c) participate in lipids absorption.
The NaCO3 from pancreatic juice neutralizes the acid chy-
me, modifying pH to optimum values for the enzymes.
The most important lipolytic enzymes are pancreatic lipase,
phospholipases, cholesteride esterase, sphingomyelinase and ce-
ramidase. The enzymes hydrolyze the dietary fats to fatty acids,
2-monoacylglycerol, cholesterol, glycerol, sphingosine, which
are absorbed by passive diffusion or micelles pinocitoza in jeju-
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num and ileum. Two processes occur within the epithelial cells in
the mucosa: re-esterification and formation of chylomicrones.
Lipids metabolism encompasses numerous catabolic and
anabolic pathways. Catabolism of polycomponent lipids produ-
ces the fatty acids. b-Oxidation of fatty acids is the principal pat-
hway for the fatty acids catabolism. It produces acetyl-CoA,
FADH2 and NADH2, which are oxidized in the Krebs cycle and
Respiratory chain and coupled with ATP production.
Biosynthesis of the polycomponent lipids requires a lot of
fatty acids, that are synthesized in cytosol from acetyl-CoA and
NADPH2. NADPH2 sources are the pentose phosphate pathway
and citrate shuttle system. Acetyl-CoA and NADPH2 are also re-
quired for biosynthesis of cholesterol and its derivatives (bile
acids, vitamin D and steroid hormones). A small amount of ace-
tyl-CoA is used for ketone bodies formation in physiological
conditions. Synthesis is limited exept under conditions of high
concentration of acetyl-CoA, when considerable production will
occur. Accompanying ketonemia (high level of ketone bodies in
the blood), there is high amount of ketone bodies in the urine
(ketonuria).
Lipid metabolism disorders results in quantitative and/or
qualitative changes in the blood or tissues lipids (dislipidemias
and lipidoses). There are inborn familial dislipidemias (primary)
and one (secondary), which is due to disease (diabetes mellitus,
alcoholism, etc.). The most frequent lipidoses are obesity and
cholelithiasis.
LESSON 17
Lipids: classification, structure, physico-chemical
properties, role
Experiment 1: Total lipids assay in blood serum (nephe-
lometric method).
65
Method principle: Lipids, that were extracted from serum
with H2SO4 forming an emulsion. It optical density is proportio-
nal to the quantity of the lipids.
Procedure:
№ Reagents Test-tubesTest Control
1 Blood serum 0,2 ml –
2 Ethanol-ether mixture (3:1) 3,8 ml –
3 Shake the solution, put it in a bath 50
o -70o C  and heat it to the
boil point
4 Cool the solution and filtrate it in measured test-tube (4 ml)
5 Add ethanol-ether (3:1) solution until 4 ml
6 Extract 2 ml –
7 H2SO4, 1% 10 ml 10 ml
8 Ethanol-ether solution (3:1) – 2 ml
9 Boil the solutions for 1 min
10 Cool the solutions and incubate them for 60 min at roomtemperature
11
Measure the optical density (extinction, E) of the test solution
using the red filter, 10 mm cuvettes and control solution for
comparison
12 Determine lipids quantity using the calibrate graph
Normal values: 4-8 g/l.
Calculation: E =            C =
Conclusion:
Clinical-diagnostic significance: Lipids content in serum in-
creases in diabetes mellitus, “steroid” diabetes, nephroses, biliary
cirrhosis, obesity, atherosclerosis.
Self-preparing questions
1. Biological functions of lipids.
2. Classification of lipids.
3. Lipids storage – acylglycerols: representatives, structure,
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            physico-chemical properties, biological role.
4. Protoplasmatic lipids: phosphoglycerides, sphingolipids,
            glycolipids, cholesterol; structure, physico-chemical
            properties, biological role.
5. Plasma lipoproteins: types, composition, biological role.
6. Eicosanoids: prostaglandins, leucotrienens and thrombo-
            xane; structure and biorole.
7. Fat-soluble vitamins: A, D, E, K; structure and biological
            role.
8. Biological membranes:
a) functions
b) composition and structure - fluid mosaic model of
                  S. J. Singer and G.L.Nicolson
c) major features: fluidity, motion, selective permeabili-
                  ty, asimmetry.
d) diversity and specificity of the structure and functions
                  of different membranes.
Self-testing questions
1. Which fatty acids are most frequently found in the human
            adipose tissue? Write their structure. Name the class of
            each one. What physico-chemical properties do they
            have? What are properties which confer to the
            polycomponent lipids?
2. The quantity of which lipids is constant: storage (reserve)
            and protoplasmatic ones?
a) it changes a lot;
b) it is practically constant in the human body. Explain,
                 why?
3. Why lipids are the main energetic source in the organism?
4. Write the formulas of the next lipids and show the hydro-
            philic and the hydrophobic groups. Which of them have









5. What kind of chemical bonds are formed between mem-





6. What intracellular membranes is monolayer? How are in-
             fluenced their properties by this structural particularity?
7. What are the differences between the plasmatic membra-
            ne of a normal and a tumor cell?
LESSON 18
Digestion, absorption, transport of lipids.
Lipids catabolism in tissues
Experiment 1: Phospholipase activity estimation.
Method principle: Pancreatic phospholipases hydralyze
phospholipids to glycerol, fatty acids, nitrogenous compound and
phosphoric acid. Their activity is estimated by H3PO4 produc-
tion. Phosphate is identified by molybdenum reaction: a yellow
precipitate is formed when phosphoric acid is heated with ammo-
nium molybdate.
Procedure:
№ Reagents Test-tubesTest Control
1 Yolk solution 5 drops 5 drops
2 Pancreatin solution 2 drops –
3 H2O dist – 2 drops
4 Incubate the solution for 30 min at 38o C
68
5 Molybdenic reagent 5 drops 5 drops
6 Boil the solutions
7 Precipitate (present or not)
Conclusion:
Experiment 2: Bile influence on lipase.
Method principle: The rate of lipase activity is estimated by
the fatty acids quantity that formed during lipids hydrolysis of
milk. Lipase activity is expressed in number of ml of NaOH
(0,05N) solution used for the titration of the fatty acids.
Note:
A. Pancreatic lipase cleaves triacylglycerols to the 2-acylmo
            noglycerol and two fatty acids.
B. Lipase is activated by bile acids.
Procedure: Prepare the initial solutions according to the table
below.
№ Reagents FlasksI II
1 Milk 50 ml 50 ml
2 Pancreatin solution, 5% 5 ml 5 ml
3 Bile solution 5 ml –
4 H2O dist – 5 ml
Transfer 1 ml of each mixture into two test-tubes, add 1-2
drops of phenolphthalein and titrate them with 0,05N NaOH to
rouse colour. The flasks with the mixtures incubate in a bath at
38o C. Repeat the titration 4 -5 times in 10 min intervals.
Draw up a graph, using the scale below where:
V- volume of NaOH (0,05N) solution consumed for titration (ml)
T- time of incubation (min).
Conclusion:
Experiment 3: Identification of bile acids.
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Method principle: When sucrose is treated with concentrated
H2SO4 oxymethylfurfurol is formed. It reacts with bile acids to
generate a red-violet complex.
Procedure:
 Put into a test-tube 2 drops of bile, 2 drops of sucrose and
shake the test-tube. Add 5-6 drops of concentrated H2SO4, wait
2-3 min for the result.
Conclusion:
Self-preparing questions
9. Dietary lipids and their importance.
10.  Digestion and absorption of dietary lipids.
11. Bile acids: classification, structure and functions. Meta-
               bolism of bile acids (general conception).
12. Lipids re-esterification in the epithelial cells. Transport
               of lipids in the human organism, blood plasma
               lipoprotein metabolism.
13. Lipolysis of triacylglycerols in tissues: enzymatic steps,
               enzymes, regulation.
14. Glycerol oxidation: reactions, enzymes, coenzymes, energe
              tic output (balance) of the anaerobic and aerobic pathways.
15. Fatty acid oxidation: enzymatic steps, regulation, ener
               getic output (balance).
a) oxidation of fatty acids with an even-number of car
                  bon atoms
b) oxidation of fatty acids with an odd-number of carbon
                  atoms
c) oxidation of unsaturated fatty acids
d) oxidation of fatty acids in peroxisomes.
16. Oxidation of phosphoglycerides, sphingomyelins and
               glycolipids.
17. Ketone bodies metabolism. Nature of ketone bodies,
               production, oxidation and biological role.
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Self-testing questions
1. Compare the number of ATP molecules that come out
            from complete oxidation (to CO2 and H2O) of 1 molecule
           of capronic acid and 1 molecule of glucose. Draw a
           conclusion?
2. The first three reactions of the b-oxidation of fatty acids
            are similar with the reactions from the Krebs cycle. Write
            these reactions.
3. How many molecules of ATP are formed during the com-
           plete oxidation (to CO2 and H2O) of 1 molecule of palmi-
           to-oleomarginate (C16, C18D9, C17). Explain it.
4. How many molecules of ATP are formed during the oxida-
            tion to CO2 and H2O of one molecule of b-hydroxybutiric
           acid?
5. Write the stoichiometric reaction of the glycerol oxidation
            to pyruvate. What enzymes are necessary except the
            glycolytic ones?
6. What is the consequence of carbohydrate absence on lipid
            oxidation?
7. Name and write the chemical structure of the essential fatty
            acids. What is the main dietary source of essential fatty
            acids?
8. Which of the following statements are correct regarding
            chylomicrons?
a) They are formed in the duodenum and consist of
      lipid covalently bound with protein.
b) They are formed in specialized hepatic cells and
contain mainly cholesterol and protein.
c) They are formed in blood from circulating
lipoproteins and contained about 60%
triacylglycerols.
d) They are formed in the intestinal mucosal cells
and contain about 85% triacylglycerols.
9. All statements regarding lipoprotein lipase are correct,
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           except:
a) it is localized in endothelial cell membranes
b) it also has phospholipase activity
c) it is activated by phospholipids and apoprotein CII
d) it hydrolizes the fatty acid at the 2nd carbon atom of
                  the glycerol
e) it is absent or deficient in hyperlipidemia, type I.
LESSON 19
Biosynthesis of fatty acids, triglicerides, phospholipids,
glycolipids and cholesterol
Experiment 1: Total  lipid's  assay  in  blood  serum  with
phosphovanillinic reagent.
Method principle: Blood serum lipids are hydrolyzed with
concentrated H2SO4. The final products react with phosphovani-





1. Serum 0,02 ml – –
2. Standard – 0,02 ml –
3. Water dist – – 0,02 ml
4. H2SO4 , concentrated 1,5 ml 1,5 ml 1,5 ml
5. Boil the solutions for 15 min
6. Cool the solutions
7. Hydrolysate 0,1 ml 0,1 ml 0,1 ml
8. Phosphovanilinic reagent 1,5 ml 1,5 ml 1,5 ml
9. Mix the solutions and incubate them 40 min at room tempera-ture, protecting them from light
10.
Measure the extinction (E) of the test and standard solutions
using control solutions for comparison, 3 mm cuvettes and
green filter (PEC)
Calculation: C (g/l) = (Et/Es) · 8 =                   where:
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Et - extinction of the test solution
Es – extinction of the standard solution
8 – lipids content in the standard solution (g/l).
Normal values: 4-8 g/l.
Clinical-diagnostic significance: Lipids contents in serum
increases in diabetes mellitus, “steroid” diabetes, nephroses, bili-
ary cirrhosis, obesity, atherosclerosis.
Conclusion:
Experiment 2. Determination of cholesterol content in
the blood serum.
Method principle: The addition of concentrated acetic acid,
acetic anhydrid and sulfuric acid to cholesterol forms a green-co-
loured complex (Ilyk method).
Procedure:
Liberman-Burchard solution: 5 pat. acetic anhydrid, 1 pat.
H2SO4, 1 pat. CH3COOH.
N Substance (solution) Test Control
1. Liberman-Burchard solution 2,1 ml 2,2 ml
2. Blood serum 0,1 ml –
20 min incubation at to=25o C
Determine extinction (E) of test solution in comparison with control
solution using the photoelectrocolorimeter (l=5 mm, l=630 nm)
Calculation: Use the calibrate curver.      E =            C =
Norma: 2,97 – 8,4 mmol/l.
Clinico-diagnostic means: Cholesterol content increases in




5. Biosynthesis of fatty acids (site, enzymes, coenzymes, re-
            gulation):
· saturated with even-number of carbon atoms
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· unsaturated with even-number of carbon atoms
· saturated with odd-number of carbon atoms.
6. Production of triacylglycerols: substrates, enzymes, regu-
            lation.
7. Biosynthesis of phosphoglycerides: substrates, de novo
            and salvage pathways, enzymes and coenzymes,
            regulation. Lipotropic compounds, their role.
8. Sphingolipids and glicolipids biosynthesis: substrates, main
            reactions, enzymes and regulation.
9. Cholesterol metabolism. Cholesterol biosynthesis: sub-
            strates, stages, reactions of the 1st stage, enzymes,
            coenzymes, regulation, utilization and elimination.
10. Eicosanoids. Cyclooxygenasic and lipooxygenasic path
              ways of their biosynthesis. Role of eicosanoids in the
              human organism, their inactivation.
11. Fat-soluble vitamins (A, D, E, K) metabolism: dietary
                sources, nutritional requirements, functions and
                metabolism.
Self-testing questions
1. Compare the following statements for oxidation and
      biosynthesis of the fatty acids:
a) location (cite) in the cell
b) “acyl”-residue transport through mitochondrial mem
                  brane
c) oxidative and reducing agents
d) polyenzymatic systems.
2. What are the main two biochemical processes that formed
           NADPH2 required for the fatty acids biosynthesis? Write
           the reactions in which are formed NADPH2 directly.
3. Write the reactions of arachidonic acid biosynthesis. What
           are its functions in the organism?
4. Why ethanol may be transformed in fat and can not be
     transformed in carbohydrates? Write the succession of
     lipid synthesis from ethanol.
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5. Explain the differences in cholesterol metabolism in case of
    its low and high diet content. What is the cause of this dif
    ference?






7. Which of the following statements about the synthesis of
    1,2,5-hydroxycholecalciferol is correct? It is synthesized:
a) from 7-dehydrocholestrol in the skin under the action
                  of ultraviolet light
b) in the liver from cholecalciferol
c) in the kidhey from 25-hydroxycholecalciferol
d) in the intestine from cholecalciferol
e) it is not synthesized in mammals.
8. What compounds are activated in the biosynthesis?
a) phosphatidylserine from serine
b) phosphatidylethanolamine from ethanolamine
c) ceramide from sphingosine
d) sphingomyelin from ceramide
e) cerebrosides from ceramides.
9. What of the following fatty acids are the precursors of the
    prostaglandins?
a) linoleic acid (C18D9,12)




Regulation and disorders of lipids metabolism
Experiment 1: Identification of ketone bodies.
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Method principle: Acetone and acetoacetate react with nitro-
prusside sodium in the presence of NaOH to form a permangana-
te colour.
Procedure:
Use only dry test-tubes!
Put in a test-tube 2 drops of urine, 2 drops of NaOH (10%)
and 2 drops of nitroprusside sodium (10%). Shake the test-tube.
Clinical-diagnostic means: Ketonemia and ketonuria occurs
in very high fat diets, in diabetes mellitus, “steroid” diabetes, al-
coholism, both normal and toxic pregnancies.
Conclusion:
Experiment 2: Determination of b-lipoproteins content in
blood serum (turbidimetric method).
Method principle: b-lipoproteins with CaCl2 and heparin
form of muddy complex. Turbidity of the solution correlates with
amount of b-lipoproteins in the blood serum.
Procedure: Put  into  a  test-tube  2  ml  of  0,27%  CaCl2
solution and 0,2 ml of blood serum, mix. Determine the extincti-
on  coefficient  (E1) of mixture in cuvete (l=5 mm, l=630 nm)
using the photocolorimeter. Then add into cuvete 0,04 ml of 1%
heparin, mix it. After 4 min of incubation at room temperature
examine this sample, using the photocolorimeter (E2).
Calculation:   C = (E2 – E1) × 100  UC
Norma: 35 – 55 UC
Conclusion:
Clinical-diagnostic means: b-lipoproteins amount increases
in blood serum in patients with atherosclerosis, diabetes mellitus,
“steroid” diabetes, obesity. Decrease of b-lipoproteins amount in
the blood serum takes place in b2-plasmacytome.
Self-preparing questions:
1. Regulation of lipid metabolism in the cell.
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2. Hormonal regulation of lipid metabolism. Role of lipotro-
    pins, ACTH, thyroid hormones, insulin, glucagon, gluco-
    corticoids and catecholamines.
3. Interrelationship between metabolism of the proteins, car-
    bohydrates and lipids.
4. Disorders of lipids digestion and absorption. Pancreatic,
    hepatic and intestinal steatorhea.
5. Dislipemias:
a) Hypolipemias: Tangier disease, a- and b-lipoprote-
                  inemia
b) primary hyperlipemias
c) secondary hyperlipemias in diabetes mellitus, alcoho-
                  lism, endocrine diseases. Causes, mechanism of lipids
                  metabolism disturbances, biochemical manifestations.
6. Tissular lipidoses:
a) inborn diseases: Niemann-Pick, Tay-Sachs, Krabble,
                 Gaucher's, Fabry's, metachromatic leukodystrophy,
                 GM1 gangliosidosis
b) secondary disturbanses: obesity, atherosclerosis, alco-
                  holism. Causes and mechanism of lipid metabolism
                 disorders, biochemical manifestations.
7. Hypo- and hypervitaminoses A, D, E, K, causes and mani-
    festations.
8. Role of the eicosanoids in inflammatory and allergic reac-
    tions, regulation of blood fluidity in the human organism.
Self-testing questions
1. In patient with pancreatitis (disease of pancreatic gland):
a) the digestion of lipids decreases, because the pH of
                 duodenal juice decreases
b) the absorption of lipids decreases, because the pH of
                 duodenal juice increases
c) the digestion and absorption of lipids decrease, beca-
                 use the secretion of lipolytic enzymes decreases
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d) the absorption of the B group vitamins decreases.
2. All the statements regarding familial hypercholesterol-
     emia (type I) are correct except:
a) increased LDL content
b) it is caused by LDL receptor deficiency
c) the extrahepatic biosynthesis of cholesterol is distur-
                  bed
d) a very high risk of atherosclerosis represents, espe-
                  cially in coronary artery
e) it is a rare autosomal recessive disease.
3. What disorders of lipid metabolism load to liver steatosis
    in alcoholism?
4. What class of blood plasma lipoproteins is the “positive”
    factor for risk in atherosclerosis? Call the major enzyme
    of their metabolism and write the reaction that it is
    catalyzed.
5. Hypovitaminosis K: the reasons and the mechanism of the
          metabolic disorders.
LESSON 21
Colloqium: LIPIDS METABOLISM
1. Classifications of lipids. Biological functions of lipids in
            the human organism.
2. Protoplasmatic lipids: phosphoglycerides, sphingolipids,
            glycolipids, cholesterol, cholesterides: chemical structure,
            physico-chemical properties, biological role.
3. Biological membranes: composition and structure-fluid
            mosaic model of S.J. Singer and G.L. Nicolson. Major
            features: fluidity, motion, selective permeability,
            asimmetry. Diversity and specificity of the structure and
            functions of different membranes.
4. Storage lipids-acylglycerols: representatives, structure,
            physico-chemical properties, biological role.
5. Dietary lipids and their importance. Digestion and absor-
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            ption of dietary lipids in gastro-intestinal tract.
6. Bile acids: classification, chemical structure, functions.
            Metabolism of bile acids (general conception).
7. Lipids re-esterification in the enterocytes. Transport of
            lipids in the blood, plasma blood lipoproteins
            metabolism, types, composition, biological role.
8. Lipolysis of triacylglycerols in the tissues: enzymic steps,
            regulation.
9. Glycerol oxidation: reactions, enzymes, coenzymes, ener-
            getic output of the anaerobic and aerobic pathways.
10. Fatty acid oxidation: enzymic steps, regulation, energe-
               tic output (energy balance). Oxidation of fatty acid:
· with an even number of carbon atoms;
· with an odd number of carbon atoms;
· an unsaturated;
· in peroxisomes.
11. Biosynthesis of fatty acids (location, enzymes, coenzy-
      mes, regulation):
· saturated with even number of carbon atoms;
· unsaturated with even number of carbon atoms;
· saturated with odd number of carbon atoms.
12. Synthesis of triacylglycerols: substrates, enzymes, regu-
      lation.
13. Biosynthesis of phospholipids: substrates, de novo and
      salvage pathways, enzymes and coenzymes, regulation.
      Lipotropic compounds, their role.
14. Sphingolipids and glycolipids biosynthesis: substrates,
      main reactions, enzymes and regulation.
15. Cholesterol metabolism. Cholesterol biosynthesis: locati-
     on, substrates, stages, reactions of the 1st stage, enzymes,
     coenzymes, regulation, utilization and elimination.
16. Ketone bodies metabolism: nature of ketone bodies, for
      mation, biological role.
17. Hormonal regulation of lipid metabolism: role of lipotro
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      pins, ACTH, thyroid hormones, insulin, glucagon, gluco
      cor-ticoids and catecholamines.
18. Disorders of lipids digestion and absorption.
19.  Dislipidemias:
· hypolipidemias: Tangier disease, a- and b-lipoprote-
                  inemia;
· primary hyperlipidemia;
· secondary hyperlipidemias in: diabetes mellitus, alco
                  holism, endocrine diseases. Causes, mechanism of
                  lipid metabolism disturbances, biochemical
                  manifestations.
20. Tissular lipidoses:
· inborn diseases: Niemann-Pick, Tay-Sachs, Krabble,
                 Gaucher, Fabry, metachromatic leukodystrophy, GMI
                  gangliosi-dosis;
· secondary: obesity, atherosclerosis, alcoholism.
Causes, mechanism of lipid metabolism disorders,
biochemical manifestations.
CHAPTER VII
Metabolism of simple and complex proteins
Proteins and amino acids constitute the major source of ni-
trogen for mammalian organism, they are a linking chain in cata-
bolism and anabolism of nitrogenous materials. In the adult hu-
man organism, about 400 g of protein per day are renewed. The
renewal rate for different proteins varies from a few minutes to
10  and  even  more  days.  Certain  proteins,  such  as  collagen,  are
practically not subject to renewal. On the whole, the half-life of
all the proteins in the human organism is about 80 days.
Proteolytic enzymes involved in the digestion of proteins
and peptides are synthetized and secreted into the digestive tract
cavity as proenzymes or zymogens. Proteolytic enzymes are acti-
vated in the intestinal lumen where they act on dietary proteins.
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The activation of these enzymes is effected via partial proteolysis
of their polypeptide chains. The human gastric juice contains two
structurally related proteolytic enzymes, pepsin and gastricsin,
which are derived from a common precursor. The proteolytic en-
zymes are excreted into the intestine from the pancreas as proen-
zymes: trypsinogen, chymotrypsinogen, procarboxypeptidases A
and B, proelastase. Polypeptide N-terminal amino acids undergo
cleavage by the intestinal amino-polypeptidase. In the intestinal
cells dipeptidases hydrolyze of dipeptides into two amino acids.
The available variety of proteolytic enzymes provides for com-
plete degradation of proteins to free amino acids.
Proteolysis, as it is effected in tissues, is important for rene-
wal of proteins, for the disposal of defective protein molecules,
and for the energetic mobilization of endogenic proteins (espe-
cially in starvation). The first step of protein renewal is proteoly-
sis, which is effected by tissue proteinases or cathepsins.
The catabolic pathways by which amino acids degrade to the
end-products may arbitrarily be divided into three groups: 1- ca-
tabolic pathways involving the conversion of NH2 groups; 2- pat-
hways for the breakdown of amino acid carbon frameworks; 3-
decarboxylation of amino acid a-COOH groups. The third pat-
hway is a version of the amino acid carbon framework conversi-
on, employed in the production of biogenic amines. The cleavage
of an amino group from an amino acid leads to the production of
ammonia (NH3). This process is called deamination. A direct or an
indirect oxidative deamination may be in the human organism.
Transamination, i.e. the transfer of an amino group from an
amino acid to an a-keto-acid without the intermediary formation
of ammonia. The aminotransferases, alanine aminotransferase
(ALT) and aspartate aminotransferase (AST), are both organo-
specific enzymes for liver and heart.
Ammonia is a very toxic compound, especially for nervous
system. In the organism tissues are operative mechanisms for
neutralization of NH3: 1- production of urea (liver); 2- reductive
amination; 3- production of amino acid amides (asparagine and
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glutamine); 4- production of ammonium salts (kidneys). The
major route of ammonia detoxification is urea synthesis.
The carbon frameworks of protein amino acids ultimately
convert into five products (oxaloacetate, acetyl-CoA, succinyl-
CoA, a-keto glutarate, fumarate), that are involved in the Krebs
cycle.
Conjugated (complex) macromolecules (nucleoproteins, he-
moproteins) are hydrolyzed by proteases in the gastro-intestinal
tract. The protein moiety is degraded into amino acids, and the
nonprotein moiety, via special conversion routes. The hemoglo-
bin of blood erythrocytes and of marrow cells accounts for a
major portion (~83%) of hemoproteins in the human organism.
The remainders are: myoglobin of skeletal muscles and heart
(~17%) and cellular hemoproteins: cytochromes, catalase, pero-
xidases, etc. (~1%).
After hemolysis in the spleen, the first stage of hemoglobin
degradation takes place, leading to bilirubin production. The
second stage of hemoglobin conversion takes place inside the
liver cells, conjugated forms of bilirubin, bilirubin glucuronides,
are produced. The end product of bilirubin conversion, stercobili-
nogen, is chiefly excreted.
Glycine and succinyl-CoA are the starting compounds in
heme synthesis. The enzymes involved in heme biosynthesis are
found in the marrow, nucleated erythrocytes, liver, kidneys. The
reactions leading to d-aminolevulinic acid proceed in the mito-
chondria; the production of porphobilinogen and coproporphyri-
nogen III occurs in the cytoplasm, and the synthesis of heme
from coprophorphyrinogen III, in mitochondria.
Mammals are not in need of dietary supply of nitrogenous
bases or nucleotides despite the ability of the mammalian organi-
sm to assimilate directly these nutrients with food rich in nucleic
acid. In the mammalian tissues the consumed purine and pyrimidi-
ne nucleotides are continually renewed via their synthesis from
simple compounds (glycine, aspartate, glutamine, carbamoyl phos-
phate, etc.).
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Nucleic acids undergo hydrolysis in the organism tissues
through the assistance of nucleases: DNAses and RNAses. Poly-
nucleotide chain is attacked by nucleases, it degrades into oligo-
and mononucleotides. Mononucleotides break down into free
bases, pentose and phosphate through the agency of nucleotida-
ses and nucleoside hydrolases. Purine bases are oxidized to uric
acid, and pyrimidine bases – to urea and b-alanine.
LESSON 22
Metabolism of simple proteins
Digestion of simple proteins in the gastro-intestinal tract
Bacterial putrefaction in the large intestine
Experiment 1. Examination of the of gastric juice acidity.
Method principle: The total acidity of the gastric juice inclu-
des: free hydrochloric acid, hydrochloric acid combined with pe-
ptides and proteins and other organic acids (lactic, butyric, ace-
tic, and carbonic).
Acidity of gastric juice equals the number of millilitres 0,1N
sodium hydroxide (NaOH) required for neutralization of 1000 ml
of gastric juice:
a) titration of free HCl using Topfer reagent (0,5% alcoholic
solution of DMAB, dimethylaminoasobenzene, pH=2,9-4,0);
b) titration of total acidity using phenolphtalein (pH=8,3-
10,0).
Procedure: Examination  of  free  HCl,  combined  HCl  and
total acidity made in one portion of gastric juice. 5 ml of juice put
in a small retorta, add 1 drop of DMAB and 1 drop of phenol-
phthalein, mix it and titrate, using 0,1 N NaOH from a burrete
until the last trace of orange colour disappears. Read the number
of ml (point A, for free HCl). Continue titration until the lemon
colour (point B),  and then continue titration until  the red colour
of phenolphtalein appears, titrating to the point (C) at which
further addition of alkali does not deepen the colour.
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Calculation:  Free HCl = A ml × 1000 × 0,1 / 5 ml = A× 20=
(mmol/l);
Norma = 20-40 mmol/l
Combined HCl = [(B+C)/2 – A] × 20=           (mmol/l) ;
Norma = 10-20 mmol/l
Total acidity = C × 20=            (mmol/l);
Norm = 40-60 mmol/l.           20 - coefficient for calculation.
Conclusion:
Clinico-diagnostical means:  In gastritis, gastric ulcer the
acidity of the gastric juice may be: true achlorhydria, hypoacidi-
ty, normal or hyperacidity. The gastric juice without HCl and
pepsin is called achylia.
Experiment 2. Identification of pathologic compounds in
the gastric juice (lactic acid by Uffelman reaction).
Method principle: Lactic acid with ferric chloride solution
and phenol form a characteristic greenish-yellow (canary yellow)
coloured complex.
Procedure: Put  in  a  test-tube  5  drops  of  pathologic  gastric
juice and Uffelman reagent (20 drops of 1% phenol solution + 2
drops of 1% solution FeCl3), mix.
Conclusion:
Clinico-diagnostical means: Cancer, hypoacidity of gastric
juice (gastritis).
Self-preparing questions:
1. Biological role of proteins. Adequate proteins intake. Ni-
trogenous balance.
2. Digestion mechanism of proteins in the gastro-intestinal
tract: role of HCl (hydrochloric acid) for digestion of proteins, its
neutralization in the intestinal tract.
3. Activation of proenzymes by partial proteolysis mechani-
sm.
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4. Endo- and exopeptidases, specificity of their action in
proteins hydrolysis.
5. Mechanisms of amino acids absorption in the small intes-
tine.
6. Bacterial putrefaction in the large intestine. Mechanisms
of toxins production and detoxication in the liver.
7. Cathepsins (proteolytic enzymes): breakdown of tissue
proteins to amino acids in the cells, pathologic autolysis of tissue
proteins.
8. Chemical composition of the normal gastric juice (free
HCl, combined HCl, total acidity) and its modification in patho-
logy.
Self-testing questions:
1. What kind of people have the negative nitrogen balance?
2. What is the biological value (adequate) of proteins?
3.  Which serine proteases do you know? Give examples.
4. What is indican (“animal indican”)? Write down the che-
mical reactions of its formation. Clinico-diagnostic value of
indican examination.
5. What are the mechanisms of the putrescin production and
detoxication?
6. What are the “proteins canals” of the cell membranes?
How many canals do you know for amino acids absorption into
the small intestine?
7. Mechanism of lactic acid production in the stomach.
Clinico-diagnostic means of lactic acid assay in the gastric juice.
LESSON 23
Catabolism of amino acids in tissues
Experiment 1. Urea determination in the urine with p-di-
methylbenzaldehyde.
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Method principle: Urea may be determined colorimetrically
by its reaction with p-dimethylbenzaldehyde in acidic medium
with production of yellow coloured complex. It’ optical density
is proportional to the quantity of urea in the urine.
Procedure: Put into a test-tube 0,2 ml of urine and 1,2 ml of
p-dimethylamine benzaldehyde solution (2%), mix. Time for in-
cubation of the test is 15 min at room temperature. After that, de-
termine extinction (E) of the test sample against water using the
photocolorimeter (green filter, 10 mm cuvettes).
Calculation: Urea quantity is determined using the standard
curve. E=             C=
Norm: 333-585 mM/daily.
Conclusion:
Clinical-diagnostic means: The most common cause of in-
creased urine urea nitrogen is anemia, increase breakdown of
proteins and amino acids in tissues. Urine urea nitrogen decrea-
ses in nephritis, acidosis, uremia, diseases of liver (hepatitis,
cancer).
Experiment 2. Determination of blood serum transami-
nases activity (GPT,  GOT).
Method principle: The transaminases catalyze the intercon-
version  of  keto-acids  and  amino acids,  the  amino  group is  tran-
sferred from one molecule to another.
Serum glutamic pyruvic transaminase (GPT) catalyzes the
following reaction:
    CH3                COOH                         CH3                COOH
½ ½ ½ ½
 HC-NH2   +     (CH2)2        GPT           C=O    +        (CH2)2
½ ½ « ½ ½
COOH           C=O         PALP          COOH         HC-NH2
½ ½
COOH                                                COOH
alanine a-ketoglutaric                   pyruvic          glutamic
                        acid                              acid                  acid
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Serum glutamic oxalacetic transaminase (GOT) catalyzes the
reaction:
1)
COOH                   COOH                         COOH               COOH
½ ½ ½ ½
CH2                      (CH2)2          GOT           CH2                  (CH2)2
½ ½ « ½ ½
HC – NH2                C=O           PALP        C=O             HC-NH2
½ ½ ½ ½
COOH                   COOH                       COOH                 COOH
aspartic acid a-ketoglutaric acid        oxaloacetic acid    glutamic acid
2) after that:        COOH
½
                                     CH2             DC             CH3
½ ® ½
                                      C=O          -CO2          C=O
½ ½
     COOH                           COOH
                              oxalacetic acid                 pyruvic acid
[]]
After incubation the resulting oxalacetic or pyruvic acid is
measured colorimetrically by reaction with 2,4-dinitrophenyl-hy-
drasine ( red-brown coloured complex).
Procedure:
№ Reagents Test Control
1. Substrate (GPT) alanine 0,5 ml 0,5 ml
to = 37o C 5 min 5 min
2. Blood serum 0,1 ml –
3. 0,9 % NaCl solution – 0,1 ml
to = 37o C 30 min 30 min
4. 2,4-DNPH solution 0,5 ml 0,5 ml
to = 20-25o C 20 min 20 min
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5. 0,4 N NaOH solution 5 ml 5 ml
to = 20-25o C 10 min 10 min
Read test sample against control sample in tube at l = 540 nm, l =
10 mm
Calculation:  Use calibration curve.          E=                    A=
Norma:  GPT= 0,16–0,68 mmol/ h×l    (15-75 IU/L);
             GOT= 0,10–0,45 mmol/ h×l   (10-50 IU/L).
Conclusion:
Clinical-diagnostic means:  Elevations in transaminases
activity occur in myocardial infarction, infectious mononucleo-
sis, infectious hepatitis. Enzymes are specific (organospecific)
for tissues: GPT – liver; GOT – heart.
Self-preparing questions:
1. Transamination of amino acids: enzymes, coenzymes, cli-
nical-diagnostic means.
2. Direct oxidative deamination of amino acids, its mechani-
sm, role of glutamate dehydrogenase.
3. Indirect oxidative deamination (across transamination) of
amino acids.
4. Mechanism of ammonia toxicity.
5. Mechanisms of ammonia detoxication in organism: gluta-
mine and asparagine synthesis, carbamoyl phosphate formation,
production of ammonia salts, reducing amination of a-ketogluta-
ric acid.
6. Urea production. Clinical-diagnostic means of urea deter-
mination in blood serum and urine in pathology.
7. Amino acid decarboxylation: enzymes, coenzymes. Bio-
logical role and inactivation of biogenic amines.
8. Fate of a-keto-acids, derived from amino acids, interrela-
tion with pyruvate ehydrogenase complex and the Krebs cycle
(CTA).
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9. Possible mechanisms of amino acids synthesis in the hu-
man organism.
Self-testing questions:










3. Write the chemical reactions of alanine synthesis from
glycerol.
4. Write the scheme of gluconeogenesis from glutamic acid
and explain it.
5. Calculate the number of ATP molecules which are produ-




6. Is the direct oxidation of glutamic acid an anaplerotic rea-
ction? Explain please.
7. Why are AlAT (GPT) and AsAT (GOT) called “organo-
specific enzymes”?
8. Which substances are the “transport form” of ammonia in
the blood?
9. Why are kidney glutaminase activity and urine ammonia
salts increased in acidosis?
10. Name the enzymes responsible for urea production in
the liver. How can you classify them?
11. Is the urea cycle an amphibolic process? Explain it.
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LESSON 24
Metabolism of individual amino acids.
Regulation and pathology of protein metabolism
Experiment 1. Determination of creatinine in the urine
(Folin method).
Method principle: Creatinine with picrinic acid form a colo-
ured complex in basic medium. Its optical density is proportional
to its quantity.
Procedure:
№ Reagents Test Control
1. NaOH, 10% 0,1 ml 0,1 ml
2. H2O dist – 0,1 ml
3. Urine 0,1 ml –
4. Picrinic acid solution 0,15 ml 0,15 ml
Time for incubation at room temperature is 15 min
After that H2O enters into the test-tubes to the volume of 10 ml
Measure the optical density of test sample (Et) against control (Ec) in
cuvettes(l=3 mm) using the green filter (540 nm).
Calculation: Using the calibrate curve calculate the content
of creatinine in daily urine.
                         E =                  C =
Norma: 8,8-17,7 mM (0,1-2,0 g) in male; 7,1-15,9 mM (0,8-
1,8 g) in female.
Conclusion:
Clinico-diagnostical means: Hypercreatininuria: intensive
muscle work, muscle atrophy. Hypocreatininuria: leukemia, kid-
ney diseases.
Experiment 2. Identification of homogentisin (hydrochi-
noacetic) acid in the urine.
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Phenylalanine and tyrosine intracellular breakdown into fu-
maric and acetoacetic acids. The intermediate of this process is
homogentisin (hydrochinonacetic) acid, which is not present in
norm in the human urine. In patient with molecular disease (alka-
ptonuria) takes place of homogentisin acid oxidation to its alka-
ptones.
Method principle: Homogentisin acid in presence of molib-
denic reagent forms the blue coloured complex.
Procedure:
№ Reagents Test Control
1. Urine (pathologic) 2 drops –
2. Urine ( norma) – 2 drops
3. H2O dist 10 drops 10 drops
4. K2HPO4, solution (10%) 4 drops 4 drops
5. Molibdenic reagent 4 drops 4 drops
Mix the solutions in the test-tubes and write the colour
Conclusion:
Experiment 3. Identification of phenylpyruvic acid in the
urine.
Method principle: A dark green colour that disappears after
addition of a few drops of ferric chloride solution to phenylpyru-
vic acid.
Procedure: 8-10 drops of 10% ferric chloride solution add to
2 ml urine. The dark green colour disappears in 30-60 sec.
Conclusion:
Clinical-diagnostic means: Phenylketonuria  is  a  disease  in-
herited through a single autosomal recessive gene so that both
parents of the patient must have the genetic defect.
Self-preparing questions:
1. Metabolism of phenylalanine and tyrosine. The main pat-
hways and disorders of these amino acids.
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2. Metabolism of glycine, serine and cysteine. The role of
tetrahydrofolic acid (THFA) in their metabolism. The mechani-
sm action of sulphanilamides.
3. Metabolism of methionine. The lipotropic factors.
4. Metabolism of triptophan. Production of vitamin PP, se-
rotonine.
5. Metabolism of dicarboxylic amino acids, their utility as
drugs.
6. Regulation and pathology of protein metabolism.
7. Interrelation of proteins, carbohydrates and lipids metabo-
lism.
Self-testing questions:




d) creatine and creatinine.








4. Glutamine is utilized in the formation of:




5. Aspartic acid is utilized in synthesis of:





6. Tyrosine is a substrate for production of:
a) DOPAmine;
b) noradrenalin and adrenalin;
c) thyroxine;
d) melanine.





d) phenylketonuria. Why may the mental development
(dementia infantilis) occur in children?
CHAPTER VIII
Metabolism of nucleoproteins and chromoproteins
LESSON 25
Metabolism of nucleoproteins
Experiment 1. Determination of uric acid in the urine.
Method principle: Uric acid is determined by reducing the
action upon a phosphotungaric acid solution, thus producing the
blue colour. The intensity of coloured solution is proportional to
the quantity of the uric acid.
12 Na2WO4 + 9 H3PO4 ®   P(W2O7)6H7 + 8 Na3PO4 + 10
H2O
Procedure: 1,5 ml of urine, 1 ml of 20% NaOH and 1 ml of
phosphotungaric acid solution put into a test-tube. Mix and titrate
it with 0,01N solution of K3Fe(CN)6 untill the blue colour
appears.
Calculation:  Cur= 0,8×a× b / 1,5 mg per day (24 h)=
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0,8 – content of uric acid, which is used for titration of 1 ml
K3Fe(CN)6  (mg)
a - content of K3Fe(CN)6 is used for titration  (ml)
b – daily urine (ml).
Norma:  1,6 - 3,54 mM (270 - 600 mg) daily.
Clinical-diagnostic means: The  content  of  uric  acid  in  the
urine decreases in kidney diseases; it increases in intensive cata-
bolism of nucleoproteins, gout, leukemia.
Conclusion:
Experiment 2. Determination of  uric  acid  content  in  the
blood serum.
Method principle: Uric acid is determined by its reducing
action upon a phosphotungaric acid solution, producing a blue
colour that is measured using the photometer.
Procedure:
Put  1  ml  of  the  blood  serum,  2  ml  H2O  dist  and  1  ml
trichloracetic acid (CCl3-COOH) into a centrifuge test-tube. Mix
and incubate it for 5 min (to = 20-25o C). After that centrifugate it
for 5 min at 600 g (2500 – 3000 rpt/min). Then examine the su-
pernatant:
№ Reagents Test Standard Control
1. Supernatant 2 ml – –
2. Standard solution (C=5,95 mM),100 mg% – 2 ml –
3. H2O dist – – 2 ml
4. Na2CO3 solution 0,9 ml 0,9 ml 0,9 ml
5. Phosphotungaric acid solution 0,1 ml 0,1 ml 0,1 ml
 In 10 min read the test and standard samples in comparison
with control sample, using the photocolorimeter at l = 710 nm in
l = 5 mm cuvettes.
Calculation:
   Et
Ct = ¾¾ × Cst × a  =          (mM/l) ,    a – dilution of the test (4).
          Est
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Norma: 0,13 – 0,40 mM/l.
Clinical-diagnostic means: Increased (hyperuricemia) blood
levels have been reported in the acute stages of infarction disea-
ses, excessive exposure to X-rays, multiple myeloma, leukemia,
gout. Blood uric acid decreases (hypouricemia) in anemia.
Experiment 3. Urea  determination  in  the  blood  serum
with diacetylmonooxime.
Method principle: Urea may be determined colorimetrically
by its reaction with diacetylmonooxime, thiosemicarbozone and
ferric chloride. This complex has red colour.
Procedure:
№ Reagents Test Standard Control
1. Blood serum 0,01 ml 0,01 ml –
2. Standard solution of urea(C=15 mmol/l) – 0,01 ml –
3. H2O dist – – 0,01 ml
4. Colour solution 2,0 ml 2,0 ml 2,0 ml
Mix, time for incubation = 20 min (to =100o C).
Read test (Et) and standard (Est) samples in comparison with
control  sample  using  the  photocolourimeter  at l=540 nm in
cuvettes (l=3 mm).
Calculation: C= Cst × Et / Est =           (mmol/l).
Norma: 2,50 - 8,33 mmol/l.
Clinical-diagnostic means: The most common cause of in-
creased blood urea nitrogen is inadequate excretion usually due
to kidney disease or urinary obstruction, malignancy.  Blood urea
nitrogen usually decreases in liver diseases.
Self-preparing questions:
1. Nucleoproteins. Digestion and absorption of nucleoprote-
ins in the gastro-intestinal tract: enzymes, mechanisms.
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2. Biosynthesis of purine nucleotides “de novo”: use of the
nitrogenous bases (substrates, enzymes, coenzymes, its regulati-
on).
3. Biosynthesis of pyrimidine nucleotides: substrates, enzy-
mes, coenzymes, regulation. The role of tioredoxin in production
of deoxyribonucleotides.
4. Catabolism of nucleoproteins in the tissues.
5. Catabolism of purine nucleotides, end products. Hyperu-
ricemia, gout (podagra).
6. Catabolism of pyrimidine nucleotides (general overview),
end products.
Self-testing questions:






e) carbon dioxide (CO2).




c) CO2 and NH3;
d) b-alanine.
3. What do you know about chemical mechanism action of
F-uracil as cell growth inhibitor?
LESSON 26
Metabolism of chromoproteins (hemoproteins)
Experiment 1. Determination of bilirubin content in the
blood serum.
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Principle: Diazoreagent with direct (conjugated) bilirubin
form a pink-coloured complex. The indirect (free) bilirubin can
be transferred in a dissoluble condition by attachment to serum
of caffeinic reagent, which increases the dissolubility of this pig-
ment and allows determine it with the diazoreagent. The intensity
of the coloured complex (azobilirubin) is proportional to the con-
centration of bilirubin and can be determined photometrically.
The  general  contents  of  both  bilirubin  types  in  the  blood  serum
are common bilirubin. Indirect bilirubin content is determined as












1. Blood serum 0,5 ml 0,5 ml 0,5 ml
2. NaCl solution (0,9 %) 1,75 ml – –
3. Diazoreagent 0,25 ml 0,25 ml –
4. Caffeinic reagent – 1,75 ml 1,75 ml
The first sample (I) incubates during 10 min at room
temperature; the second sample (II) – 20 min. Extinction of both
samples and control determine against water at the green light
filter (l=530 nm) use photometer:
Edb , Ecb , Ec .
Calculation: Find  the  contents  of  a  general  (common,  Ccb)
and direct bilirubin (Cdb) in calibration curve. Use these contents
for calculation of indirect bilirubin (Cib):
Cdb =                 mcmol/L ;   Ccb=                   mcmol/L
Cib = Ccb – Cdb =                     mcmol/L
Norma: 1,7-20,5 mcmol/L –  general (common) bilirubin;
              1,86-4,3 mcmol/L –  direct bilirubin;
              1,7-17,1 mcmol/L –  indirect bilirubin.
Conclusion:
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Clinical-diagnostic means: The contents of the general
(common) bilirubin exceed the norm (hyperbilirubinemia) in
icteruses: mechanical (direct bilirubin), hemolytic (indirect), pa-
renchymatous (direct and partially indirect). An increase of bili-
rubin is marked in a physiologically icteric newborn basically of
indirect, that is connected to a functional hepatic insufficiency, in
particular, insufficient activity of an enzyme UDP-glucuronyl-
transferase, necessary for formation of direct (conjugated) biliru-
bin in the liver.
Self-preparing questions:
1. Types of chromoproteins, their localization in the cell.
2. The main characteristics and biological role of chromo-
proteins (hemoproteins).
3. Digestion of chromoproteins in the gastrointestinal tract:
enzymes, products of digestion in the intestine, their absorption.
4. Hemoglobin catabolism in the tissues: bilirubin formation
and excretion. The interrelation between bile pigments of blood
serum, urine and excrements (faeces).
5. Jaundices (icteruses). Differential biochemical diagno-
stics of jaundices (icteruses).
6. Heme biosynthesis. Biosynthesis of hemoglobin and its
regulation. Pathology of this process.
Self-testing questions:
1. Write the formula of a heme.
2. What  is  destiny  of  an  exogenic  (nutritional)  heme in  the
human organism?
3. What matters are hemolytic poisons?
4. Why are vitamins B12 and folic acid antianemic factors?
5. What do the hemoglobins of various kinds of organisms
differ by? Explain their likeness.
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6. Why is not bilirubin found in the urine of the patients
with hemolytic icterus?
7. Icteruses (jaundices). Differential biochemical diagnostics
of icteruses, explain it.
LESSON 27
Colloqium: Metabolism of simple proteins, nucleo- and
chromoproteins
1. The biological means of proteins. Complete and income-
plete proteins.
2. Digestive mechanism of proteins. Mechanism activation
of pepsinogen, and its specificity.
3. Mechanism activation of trypsinogen and chymotrypsino-
gen. Specifity of trypsinogen and chymotrypsinogen.
4. Mechanism activation and specificity of procarboxypepti-
dase, proaminopeptidase and prodipeptidase.
5. Mechanism activation and specificity of proelastase. Me-
chanism neutralization of HCl in the intestine (write the reaction
of HCl neutralization).
6. Mechanism of digestion of nucleoproteins in the intesti-
ne. Absorption of products in the intestine.
7. Mechanism of absorption of protein hydrolyzates (amino
acids). The role of Na+,K+- ATPase and g-glutamyl transferase
(GGT) in this process.
8. Pathology of proteins digestion and absorption of products.
9. Breakdown of proteins into amino acids in the tissues.
10. Direct oxidative deamination (of glutamic acid).
11. Indirect oxidative deamination (transdeamination).
12. Transdeamination. The role of GPT and GOT in the or-
ganism, write down the reactions of transamination.
13. Decarboxilation of amino acids. Production of histami-
ne, serotonine and g-aminobutyric acid (GABA). The biological
role and mechanism of inactivation (detoxification) of biogenic
amines.
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14. Mechanism of ammonia toxication, write down the rea-
ction, explain it.
15. Routes of metabolic detoxification of ammonia. Am-
monium salt production.
16. Production of asparagine and glutamine.
17. Production of urea, write down the reactions.
18. Breakdown of nucleotides in the organism tissues (puri-
nes and pyrimidines). Production of uric acid (write down the
reactions).
19. Biosynthesis of mononucleotides (purines and pyrimi-
dines).
20. Hemoglobin catabolism in the tissues, bilirubin forma-
tion and excretion. The interrelation between bile pigments of
blood serum, urine and excrements (faeces). Differential bioche-
mical diagnostics of icteruses (jaundices).
21. Heme biosyntesis, its regulation and pathology.
22. Metabolism of phenylalanine and tyrosine. The main
pathways and disorders of amino acids metabolism.
23. Metabolism of glycine, serine and cysteine. The role of
tetrahydrofolic acid (THFA) in their metabolism. Mechanism
action of sulphanilamides.
24. Metabolism of methionine and tryptophan. Lipotropic
factors. Production of vitamin PP and serotonine.
25. Metabolism of dicarboxylic amino acids, their utility as
drugs.
26. Interrelation of proteins, carbohydrates and lipids meta-
bolism.
27. Bacterial putrefaction in the large intestine. Mecha-
nisms of toxins production and their detoxification in the liver.
CHAPTER IX
Neuroendocrine control of metabolism
The neuroendocrine system includes special glands whose
cells function is to secrete chemical regulators, commonly refe-
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rred to as hormones, into the internal media of the organism, i.e.
blood and lymph. The hormone-secreting glands are subdivided
into the central glands (hypothalamus, pituitary gland) and the
peripheral glands (thyroid, parathyroid, adrenal glands, etc.). By
their chemical structure, hormones are subdivided into: protein-
peptide hormones (insulin, calcitonin, vasopressin), amino acid
derivatives (adrenalin), steroids (corticosteroids, sex hormones).
The required level of the hormone in the blood is maintained
owing to the self-regulation mechanism. This mechanism is
based  on  interhormonal  relationships  which  are  referred  to  as
“plus-minus” interactions, or mutually exclusive relationships.
Hormones, which are secreted by the glands into the blood,
usually become bound to specific blood plasma transport proteins
to be carried to the peripheral tissues, where they exert influence
on metabolism and tissue function. The possible types of action
for extracellular regulators (referred to as first messengers), in-
cluding hormones, are: membrane, or local, action; membrane in-
tracellular, or indirect, action; cytosolic, or direct, action.
For practical applications, hormones are produced by extra-
ction from biological materials, by chemical synthesis, or by ge-
netic engineering methods. Practically all the protein hormones
can be prepared by laboratory synthesis. Insulin, somatostatin
and related hormones have been prepared by the genetic enginee-
ring method in the laboratory.
In medical practice, hormones are used for substitution
therapy and pathogenetic therapy. In the latter instance, certain
specific properties of hormones (antiinflammatory, anabolic,
etc.) are made use of, even though if the hormonal concentrations
in the organism may be at anormal level.
Antihormones are compounds that exhibit antihormonal
activity through binding to cytosolic receptors. The molecular
mechanism of antihormonal action is based on the competition
for binding sites with the corresponding cytosolic receptors. Na-
tural antihormones include estrogens and androgens which com-
pete with each other for binding with the receptors of opponent
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hormone: estrogens block the androgenic receptors, and androge-
ns, the estrogenic ones.
Prostaglandins are hormone-like compounds (hormonoids)
derived from C20-polyene fatty acids containing a cyclopentane
ring. Prostaglandins are short-lived species that are synthetized at
need in small amounts to exert a local biological effect at the site
of their formation. An excessive production of prostaglandins or
their deficiency may lead to pathologic processes such as infla-
mmation, thrombosis, gastric ulcer, and others. Prostaglandens
use in practice as drugs, for example, prostaglandin E2
(dinoprostone  and  prostin  E2) is applied in arresting bronchial
apasmodic attacks, hypertension, and peptic ulcer.
LESSON 28
Hormones: chemical structure, biorole, mechanism of
action, synthesis. Hormones of hypothalamus,
hypophysis, parathyroid glands
Experiment 1. Determination of calcium in the blood
serum.
Method principle: The method  is  based  on  the  titration  of
calcium iones (Ca2+) in alkali medium by sodium salt of ethylen-
diamine tetraacetic acid (EDTA) in the presence of murexid as
indicator.
Procedure: Put 50 ml of H2O dist, 0,4 ml of 9N NaOH solu-
tion and a small  amount of murexid,  mix it  (violet  colour).  The
solution is divided into two portions and transferred into 2 retorts
(muffles). One portion will be as the control, another one as the
test.  Add 1  ml  of  blood  serum into  the  test-muffle.  Serum Ca2+
and murexid produce a pink-violet complex. After that titrate the
test with EDTA solution until the violet colour is obtained
102
(reverse). The end of titration is a relative colour of test and con-
trol samples.
Calculation:   Ct = 1,76 × a =         mmol/l;   a – number of ml
EDTA for titration of test.
Norma:   2,25 – 2,75 mmol/l  blood serum.
Clinico-diagnostical means: Hypocalcemia: hypoparathyroi-
dism, hyperthyroidism, uremia. Hypercalcemia: hypervitamino-
sis D, hyperparathyroidism, osteosarcoma.
Conclusion:
Self-preparing questions:
1. Hormones: definition, overview of the chemical nature,
mechanisms of action, usage of the hormones as drugs.
2. Central  regulation  of  the  hormone  functions:  the  role  of
hypothalamus and hypophysis.
3. Classification and properties of hormones.
4. Mechanisms of hormones action:
membrane-cytosolic (indirect) mechanism of action, role
 of G-protein and second
messengers in the transfer of the hormonal information;
cytosolic (direct) mechanism of metabolic control.
5. Hormones of hypothalamus (liberins and statins).
6. Hormones of hypophysis. Chemical nature, mechanism of
action, biological effect, regulation of secretion, utility as drugs
in the therapy.
corticotropin family hormones (ACTH, lipotropin);
glycoprotein family hormones (FSH, TSH, LH and
gonadotropin-chorionic-placentar);
somatotropin family hormones (STH, prolactin and
lactogenic placentar);
vasopressin and oxytocin.
7. Hormones of parathyroid glands. Regulation of phosphate
and calcium metabolism. Parathyrin and vitamin D interrelation.
Disorders of parathyroid glands functions.
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Self-testing questions:
1. What is the difference between hormones and hormonoids
(parahormones)?
2. Name the hormones of central and peripheral glands.
3. What do you know about the extracellular regulators
called the first messengers?
4. Write the chemical structure of the secondary messenger:
a) 3’,5’-cAMP;
b) 3’,5’-cGMP.






6. Which is the mechanism action of parathyrin influence on
phosphorus-calcium metabolism through vitamin D?
LESSON 29
Hormones of thyroid and pancreatic glands
Experiment 1. Determination of inorganic phosphate
content in the blood serum.
Method principle: Phosphate ions along with ammonium
molibdate form the ammonium phosphomolibdate in the acidic
medium, which together with ascorbic acid form the blue-colou-
red complex. Its optical density is proportional to the quantity of
phosphate.
Procedure:
№ Reagents Test Control
1. Blood serum 1 ml –
2. H2O dist 4 ml 2,5 ml
3. TCA (trichloracetic acid), 10% 5 ml 2,5 ml
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Centrifugation: 10 min at 600 g
4. Centrifugate (supernatant) 5 ml –
5. Ammonium molibdate solution 1 ml 1 ml
6. Ascorbic acid solution, 1% 0,2 ml 0,2 ml
Incubation at room temperature: 20 min. After that use photocolori-
meter  (red filter) for determination of the optical density (E) of the
test sample against control.
Calculation: Use the calibrate curve.   E =               C =
Norma: 0,58 - 0,84 mmol/L (1,8 - 2,6 mg/100 ml).
Conclusion:
Clinical-diagnostic means: Phosphate content is decreased
in patients with hyperparathyroidism, and increased in diseases
of kidney, hypoparathyroidism, diabetes mellitus.
Experiment 2. Insulin identification.
 Hormone insulin is a simple protein. Perform the following
chemical reactions:
a) The biuret reaction (Piotrovskii): identification of the
peptide chemical bond.
(see Lesson № 1, task 1).
Conclusion:
b) Identification of the sulfur-containing amino acids (Fol
test).
(see Lesson 1, task 4).
Conclusion:
Self-preparing questions:
1. Hormones of the thyroid gland: iodothyronines and thyro-
calcitonin, their chemical structure, mechanism of synthesis and
action, regulation.
2. Hypo- and hyperfunction of the thyroid gland, pathologi-
es, methods of their correction.
3. Hormones of the pancreatic gland: insulin, glucagon, so-
matotropin.
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4. Insulin: chemical structure, mechanism of its synthesis,
activation and inactivation. Mechanism of its action, metabolic
role. Disorders of the insulin secretion: hyperinsulinemia, hypo-
insulinemia. Pathology: diabetes mellitus (type I and II).
5.  Glucagon: chemical structure, mechanism of its action,
metabolic role.
 6. Pharmaceutic drugs: laboratory synthesis of insulin.
Self-testing questions:
4. Mechanism of insulin action (choose the right answer):
e) breakdown of glycogen into glucose;
f) transport of glucose from blood to tissues;
g) activation of Na+,K+-pump;
h) insulin increases the cell membrane penetration for
amino acids and fatty acids.
5. Processes leading to hypoglycemia:
f) transport of glucose from blood to tissues;
g) glycogen synthesis from glucose in the liver and ske-
letal muscles;
h) absorption of glucose from the intestine;
i) production of triacylglycerol from glucose in the fat
tissue;
j) gluconeogenesis (in the liver and kidney).
6. Which hormones do you know that increase the glucose







Adrenal glands hormones. Sex hormones. Hormonoides
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Experiment 1. Identification of 17-ketosteroids in the
urine.
Method principle: 17-ketosteroids with m-dinitrobenzen pro-
duce a red-violet complex in alkali medium.
Procedure: Put into the test-tube 20 drops of urine, 30 drops




1. Hormones of the adrenal glands: catecholamines and cor-
ticosteroids.
2. Catecholamines (adrenalin and noradrenalin): chemical
structure, mechanism of their synthesis, mechanism of action, re-
gulation of secretion.
3. Corticosteroids: glucocorticoids and mineralocorticoids.
Chemical structure, mechanism of action, regulation of their se-
cretion.
4. Aldosterone: chemical structure, metabolic role, patholo-
gy of its secretion.
5. Glucocorticoids (hydrocortisone, corticosterone): chemi-
cal structure, mechanism of action, metabolic role, pathology
(“steroid” diabetes).
6. Sex hormones: androgens and estrogens. Regulation of
their secretion.
a) estrogens: chemical structure, physiological role and
mechanism of action, pathology and its correction;
b) androgens: chemical structure, biological role, mecha-
nism of action, pathology and  its correction;
c) anabolic steroids (nerobolil, retabolil) as drugs.
7. Hormone-like compounds or hormonoids (local hormo-
nes, parahormones): histamine, serotonin, heparin, prost-aglan-
dins, etc.
8. Antihormones, their utility in medicine.
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Self-testing questions:
1. What is the precursor of the female and male hormones?
2. Usage of testosterone in medicine.
3. Is there any difference between patients with diabetes
mellitus and diabetes “steroid”?
CHAPTER X
Biochemistry of blood
Blood is  a  fluid  tissue  composed  of  cells  (formed elements
of the blood) and an extracellular liquid medium, plasma. The
blood cells account for about 45%, and the plasma, for about
55% of the blood volume. The clear liquid that separates from
the  blood  when  it  is  allowed  to  clot  completely  is  called blood
serum. The blood serum is the plasma from which fibrinogen has
been removed in the process of clotting. Water accounts for
about 83% of blood weight, and the dry residue of blood acco-
unts  for  the  rest.  By  its  physico-chemical  properties,  blood  is  a
viscous liquid of specific density 1.050-1.060. The blood pH
value (7.36-7.44) is maintained by buffer systems at a constant
level. Its variations do not exceed 0.05-0.10 pH unit.
Biochemical and physiological functions of the blood are de-
fined by a cooperative participation of the blood cells and chemi-
cal components of the blood plasma in metabolism. The blood
cells are: erythrocytes, leucocytes, lymphocytes, thrombocytes.
Blood performs the following functions: transport, osmoregulato-
ry, buffering, detoxifying, defensive, or immunologic, regulato-
ry, or hormonal, hemostatic.
The transport function is the major function of the blood. A
variety of materials are transported in the blood by mechanical
transport: nutrients, gases (O2 and CO2), hormones, vitamins, etc.
Blood maintains osmotic pressure inside the blood vessels. This
function is carried out by blood plasma proteins, chiefly albumi-
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ns, and by Na+ cations. Inside the erythrocytes, the role of osmo-
tic pressure regulation is assigned to hemoglobin and K+ ions.
The lowered blood plasma concentration of proteins, or hypopro-
teinemia, leads to a decrease in the oncotic pressure in blood ca-
pillaries and to oedematous disturbances.
The detoxifying function of the blood provides for detoxifi-
cation and neutralization of materials supplied to the blood.
Detoxification is effected by diluting the toxicants and their bin-
ding mainly to the albumins of the blood plasma. Passive neutra-
lization of toxicants can be actively detoxified by enzymes found
in the blood plasma and blood cells.
The blood cells and blood plasma are sources for production
of various extracellular regulators involved in the control of me-
tabolism and functions of tissues and organs. These regulators
belong to local hormones, or hormonoids: serotonin, histamine,
heparin, etc. The blood plasma proteins serve as substrates for
the formation of biologically active polypeptides grouped under
the common name kinins. They include bradykinin, kallidin,
methionyl-lysyl-bradykinin. Under physiological conditions, the
systems of production and inactivation of kinins are equilibrated.
Pathologic alterations occur due to an excessive kinin generation,
which is concomitant with the development of local inflammations
and impaired blood circulation.
Hemostasis, or arrest of bleeding to prevent blood loss, is an
important function of the blood. The blood coagulation system,
thrombocytes, and vascular wall are involved in this process.
Blood clotting is a multistage self-accelerating process in which
plasmic and thrombocytic factors are involved. To date, 13 plas-
mic and 11 thrombocytic factors have been described. In the or-
ganism blood coagulation is controlled by agents that either acce-
lerate the process (procoagulants) or decelerate it (anticoagulants).
Natural anticoagulants include heparin, and procoagulants,
vitamin K and Ca2+ ions.
Blood is used as raw material for producing a variety of me-
dicinal preparations which, by their therapeutic applications, are
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divided into four groups: systemic effect agents (albumin, prote-
in, blood plasma); immunologically active preparations (g-globu-
lin, interferon, etc.); hemostatic preparations (thrombin, fibrino-
gen, fibrin film, fibrin sponge); antianemic and stimulating pre-
parations (polyobolin, eryheme).
LESSON 31
Blood: metabolism of blood cells, chemical components
of blood plasma
Experiment 1. Determination of total protein in the blood
serum by refractometric method.
Principle: This method is based on the Tindal’s effect.
Light-ray that runs through a protein solution is refracted. There
is a correlation between refracted light-corner and protein con-
centration.
Procedure: Put  1  drop  of  water  on  the  surface  of  refractto-
metric set and close it. The line between the light semicircle and
dark  semicircle  must  be  on  the  medium  position  of  the  cycle:
a=1,336o (water-dependent zero). After that put 1 drop of blood
plasma on the surface of the set and close it. The line of the light
and dark semicircles changes its position. Return it to medium
position and determine the light-corner.
Calculation: Use the table data for determination of the
protein concentration.
a=                   C=
Norma:  65-85 g/l.
Conclusion:
Clinical-diagnostic means: The protein content decreases in
nephritis, cirrhosis, starvation, hemorrhage, etc., this condition is
named hypoproteinemia. Hyperprotein-emia is specific for mye-
loma, vomiting, diarrhea, dehydration, etc.
Experiment 2 Quantitative assay of the serum total
protein (Biuret method).
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Principle: The assay is based on Biuret reaction.
Procedure:
№ Reagents Test Control
1. Blood serum 0,1 ml –
2. H2O dist – 0,1 ml
3. Biuret reagent 2,9 ml 2,9 ml
Incubation at room temperature for 30 min
Measure the extinction of the test sample in comparison with the
control solution. Use the photocolorimeter: 10 mm cuvettes, green
filter (l = 540-560 nm).
Calculation: Protein quantity is estimated using the calibrati-
on curve. E=         C=
Normal values: 65 - 85 g/l.
Clinical-diagnostic means:  see Experiment 1.
Conclusion:
Self-preparing questions:
1. Blood biological functions.
2. Blood  cells:  types,  biorole,  chemical  components.  Pecu-
liarities of blood cells metabolism (erythrocytes, leucocytes, lym-
phocytes, thrombocytes).
3. Chemical components of blood plasma:
a) proteins of blood plasma (albumins, globulins, immu-
noglobulins, lipoproteins, interferon);
b) enzymes: characterictics, role of organospecific enzy-
mes and isoenzymes (LDH, CPK, etc.) in diagnostics.
c) plasma non-proteic nitrogen compounds: fractions,
clinico-diagnostical means in pathology. Hyperammonemia and
hyperuremia, correction of these pathologies (hemodialysis, he-
mosorbtion).
4. Plasma non-nitrogenic organic compounds.
Self-testing questions:
1. Hemoglobin variants in the human organism.
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2. What is the detoxifying function of the blood?
3. Write the chemical reaction catalyzing the carboanhydrase
and explane it.
4. Explain the difference between metabolic and respiratory
acidoses.
5. Organospecific isoenzymes are:
a) LDH1 and LDH2;
b) LDH4 and LDH5;
c) creatine phosphokinase (CPK): BB, MB and MM iso-
forms.
6. Why are vitamins B12 and foleic acid antianemic factors
(drugs)?
LESSON 32
Physico-chemical properties of the blood plasma
Experiment 1. Determination of iron in biological liquids
with rodanide (CNS-).
Principle: Iron (Fe) interacts with rodanide producing a red-
coloured complex. Its optical density is proportional to the iron
amount.
Procedure: Blood serum and extracts of tissues may be used
for the assay. Previously to the assay the samples are treated with
sulfuric acid and hydrogen peroxide. After the filtration of this mi-
xture, take 4 ml of the filtrate and put it into a test-tube. Also put 3
ml of H2O dist and 1 ml of potassium rodanide (20%) into the test-
tube,  mix  it.  In  5  min  read  the  test  sample  (E)  against  water  in
photometer using blue filter (490 nm) and 10 mm cuvettes.
Calculation: Use the graph.   E=               C=
Norm:  male: 16,1 - 21,1 mM/l;    female: 14,3 - 21,5 mM/l.
Clinical-diagnostic means:  Increased content of iron in the
blood serum is detected in liver diseases, hemochromatosis.
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Decreased one is revealed in diseases of the gastro-intestinal
tract, disorder of iron absorption in the intestine.
Conclusion:
Self-preparing questions:
1. Water and mineral metabolism:
a) water concentration and its disturbances in the organi-
sm;
b) physico-chemical properties of water;
c) water as solvent for natural substances and xenobiotics;
d) biorole of the kidney in the metabolism of water and
mineral salts;
e) regulation of osmotic pressure and exracellular me-
dium (hormonal and rennin-ngiotensinic).
2. Mineral components of blood plasma. Blood plasma iono-
gram:
a) metabolism of macroelements (sodium, potassium,
calcium, magnesium, iron, chloride, sulfate);
b) mineral compounds, role in regulation of osmotic pres-
sure (iso-, hypo- and hypertonic solutions);
c) oligo- and microelements, role in metabolism (copper,
zink, cobalt, selenium, etc).
3. The buffer systems of blood. Acid-base equilibrium, phy-
siological and physico-chemical mechanism of buffering. Acid-
base disorders (acidoses, alkaloses).
Self-testing questions:
1. Explain the difference between metabolic and respiratory
acidoses.
2. Respiratory alkalosis:
a) increases CO2 concentration  in the blood;
b) decreases CO2 concentration in the blood;
c) increases the concentration of Cl-ions in the blood;
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d) decreases the concentration of Cl-ions in the blood.
3. What is the concentration of Ca2+- ions in the blood plasma?
4. Why does the human organism need Ca2+-ions? Where is
Ca2+-stored in the human organism?
5. Where are Na+ and Cl—ions stored in the human organism?
LESSON 33
Respiratory function of the blood.
Blood clotting and anticoagulant mechanism
Experiment 1. Hemoglobin assay in the blood by cianme-
themoglobinic method.
Principle: Potasium ferricianid oxidies hemoglobin in me-
themoglobin. In the presence of acetoncianhydrin it forms a red-
coloured complex. Its optical density is proportional to the quan-
tity of the hemoglobin.
Procedure:
№ Reagents Test Control
1. Transformic reagent (solution) 5,0 ml 5,0 ml
2. Blood 0,02 ml –
Incubation at room temperature – 10  min.  After  that  read  the  test
sample (E) against transformic reagent in photometer using green
filter and 10 mm cuvettes.
Calculation: Hemoglobin quantity is determined using the
standard curve. E=           C=
Normal values:  males: 132 - 164 g/l;  females: 115 - 145 g/l.
Conclusion:
Clinical-diagnostic means: Hypohemoglobinemia: irondefi-
ciency anemia, hemorragia. Hyperhemoglobinemia: erythremia,
dehydration.
Self-preparing questions:
1. The respiratory function of the blood.
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2. Oxygen transport: the role of hemoglobin in this process,
cooperative mechanism and the sigmoidal curve of oxyhemoglo-
bin formation. Regulation of hemoglobin affinity to oxygen (2,3-
biphosphoglycerate, protons, temperature).
3. Disorders of oxygen transport: hypoxemia and hypoxia,
types, causes.
4. Transport of CO2 from the tissues to the lungs. Henderson
cycle.
5. The biochemical mechanism of blood clotting. Modern
theory of hemostasis. Factors and pathways of blood coagulation.






1. Vitamins K and D are procoagulants. Explain their role.
2. Explain the mechanism action of antivitamins K (dicou-
marol, pelentan) on the blood clotting.
3. What is the difference between oxyhemoglobin A (Hb A)
and oxyhemoglobin F (Hb F)?
4. What do you know about the disease “hemophylia”?




1. Hormones: chemical structure, classifications.
2. Mechanisms of hormones action:
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a) membrane-cytosolic (indirect) mechanism of action,
role of G-protein and second messengers in the transfer of the
hormonal information;
b) cytosolic (direct) mechanism for metabolic control.
3. Central regulation of the hormone functions: role of hy-
pothalamus and hypophysis.
4. Hormones of hypothalamus, chemical nature, biorole.
5. Hormones of hypophysis: chemical structure, mechanism
of action, biological effect, regulation of secretion, utility in the-
rapy.
6. Hormones of parathyroid glands: regulation of calcium and
phosphate metabolism. Parathyrin and vitamin D interrelation.
Disorders of parathyroid glands functions.
7. Hormones of thyroid gland: thyroxin, calcitonin. Biosyn-
thesis, regulation, hypo- and hyperfunction of thyroid gland, pat-
hologies, methods of their correction.
8. Hormones of pancreatic gland: insulin, glucagon, somato-
tropin. Their characteristics and metabolic role.
9. Insulin: chemical structure, mechanism of its synthesis,
activation and inactivation. Mechanism of its action, metabolic
role. Disorders of insulin secretion: hyperinsulinemia, hypoinsu-
linemia. Pathology: diabetes mellitus (type I and II).
10. Glucagon: chemical structure, mechanism of its action,
metabolic role.
11. Hormones of adrenal glands: adrenalin, noradrenalin.
Mechanism synthesis and action, metabolic role, regulation of
secretion.
12. Corticosteroids (glucocorticoids): chemical structure,
mechanism of action, metabolic role, regulation of secretion, di-
sorders (“steroid” diabetes).
13. Aldosterone: chemical structure, metabolic role, patho-
logy of its secretion.
14. Sex hormones: estrogens and androgens, chemical struc-
ture, mechanism of action, utility in medicine. Usage anabolic
steroids as drugs.
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15. Hormone-like compounds or hormonoids (local hormo-
nes, parahormones): histamine, serotonin, heparin, prostaglandins,
etc. Antihormones, utility in medicine.
16. The blood biological functions and physico-chemical
characteristics.
17. Blood cells: types, biorole, chemical components. Pecu-
liarities of blood cells metabolism (leucocytes, erythrocytes, lym-
phocytes, thrombocytes, neutrophils, basophils).
18. Proteins of the blood plasma: fractions, clinico-diagno-
stical means in pathology.
19. Enzymes of the blood serum: characterictics, role of or-
ganospecific enzymes and isoenzymes (LDH, CPK, etc.) in dia-
gnostics.
20. Non-proteic nitrogen compounds: fractions, clinico-dia-
gnostical means in pathology.
21. Water-mineral metabolism: regulation of osmotic pres-
sure and exracellular medium (hormonal and renin-angioten-
sinic).
22. Mineral components of the blood plasma. The blood
plasma ionogram: metabolism of macroelements and microele-
ments.
23. The buffer systems of blood. Acid-base equilibrium,
physiological mechanism of buffering and its disorders (acidoses,
alkaloses).
24. Respiratory function of blood: oxygen transport, role of
hemoglobin in this process, cooperative mechanism, sigmoidal
curve of oxyhemoglobin formation.
25. Regulation of hemoglobin affinity to oxygen (2,3-
biphosphoglycerate, protons, temperature). Disorders of oxygen
transport: hypoxemia and hypoxia, types, causes.
26. Transport of CO2 in the blood (from tissues to the
lungs). Henderson cycle.
27. Biochemical mechanism of blood clotting. Modern
theory of hemostasis.
28. Factors and scheme of the blood coagulation.
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29. Anticoagulants: chemical nature, mechanisms of action
for natural and synthetic anticoagulants, fibrinolitic system.
30. Vitamins K and D, their interrelation with blood clot-
ting (coagulation). Hypo- and hypervitaminoses K or D, patholo-
gies and their correction.
CHAPTER XI.  SPECIAL BIOCHEMISTRY
Biochemistry of connective, bone, tooth tissues. Saliva
LESSON 35
Biochemistry of connective tissue and bone
Experiment 1. The total content of proline and hydroxy-
proline assay in the urine.
Method principle: Proline is oxidized to hydroxyproline by
lead peroxyde. Нуdroxyproline is condensed with p-dimethyl-
amino-benzaldehyde with formation of an orange-coloured com-
plex. The intensity of the colour is proportional to the total quan-
tity of proline and hydroxyproline.
Procedure:
№ Reagents Test Control
1. Urine 2,5 ml –
2. H2O dist – 5,0 ml
3. p-dimethyl-amino-benzaldehyde,5% 0,5 ml 0,5 ml
4. HCl, 2 N solution 1,0 ml 1,0 ml
Boil test-tubes for 1 min (100o C), then incubate it at room tempera-
ture for 10 min
Read the extinction (E) of the test in comparison with the control use
photocolourimeter: green filter (l = 540 nm) in the cuvette (l = 10
mm)
Calculation:  For determination of the proline and hydroxy-
proline content use the calibrate curve.    E=             C=
Norma:
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Clinical-diagnostic means: The total quantity of proline and
hydroxyproline in the urine increases in  rheumatism, trauma,
pneumonia, etc.
Conclusion:
Experiment 2. Determination of Ca concentration in the
urine ( Sulkovich method).
Method principle: Calcium and oxalate in acidic medium
form the turbidity complex. The intensity of the turbidity com-
plex is directly proportional to Ca-ions quantity in the sample.
Procedure:
№ Reagents Test Control
1. Urine 2,0 ml –
2. Sulkovich reagent 2,0 ml 4,0 ml
Incubation for 2 min at room temperature
Read the extinction (E) of the test in comparison with the control
using photocolorimeter: l = 640 nm in the cuvette (l = 5 mm)
Calculation: For  determination  of  Ca  content  use  the
calibrated curve. E=      C1=
 Use the obtained value (C1)  for  determination  of  the  daily
excretion of calcium with urine:  D= 1500 ml/24 h;    C=C1× 1,5=
g/24 h;      1,5 – coefficient for calculation.
Norma: about 0,25g / 24 h.
Clinical-diagnostic means: The quantity of Ca excreted with
urine increases essentially in hyperparathyroidism, hypervitami-
nosis D, renal pathologies, diabetes mellitus.
Conclusion:
Self-preparing questions:
1. The cells of connective tissue: the representatives, their
biological role.
2. The extracellular matrix of the connective tissue:
§ proteins (collagen, elastin): the particularities of bio-
chemical structure, biosynthesis and degradation, biological role.
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§ glucosamine glycans: representatives, their structure,
physico-chemical properties, biological role, biosynthesis;
§ proteoglycans: composition, structure, functions and
metabolism.
3.   Pathology of connective tissue metabolism:
§ age-dependent modifications;
§ acquired qualitative modifications (scurvy, diabetes);
§ genetic qualitative modifications: collagenoses, mu-
copolysaccharidoses, the causes of biochemical manifestation.
6. The cells of the bone tissue: the representatives, their bio-
logical role.
7. Mineral  components  of  the  bone  tissue:  the  main  anions
and cations, their structural organization, minor ions and olygoe-
lements, their role.
8. Organic compounds of the bone tissue: fibrilar and non-
fibrilar proteins,  proteoglycans, carbohydrates and lipids, their
structural organization and biological role.
9. Formation and resorbtion of the bone: mechanisms, enzy-
mes,  regulation.  Role  of   vitamins  D,  C and  hormones  (calcito-
nine, parathyrin) in these processes.
10. The pathology of bone tissue metabolism: age-depen-
dent, osteoporosis, skeletal fluorosis.
LESSON 36
Biochemistry of dental tissues
Experiment 1. Determination of inorganic phosphate con-
tent in the urine.
Method principle: Phosphate ions along with ammonium
molibdate form ammonium phosphomolibdate in acidic medium,
which along with ascorbic acid form the blue-coloured complex.
Its optical density is proportional to the quantity of phosphate.
Procedure:
№ Reagents Test Control
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1. Urine (diluted 1:100) 2,0 ml –
2. Molibdenic reagent 1,0 ml 1,0 ml
3. Ascorbic acid solution, 1% 2,0 ml 2,0 ml
4. H2O dist – 2,0 ml
Read the extinction (E) of the test in comparison with the control
using the photocolorimeter: wavelength l = 640 nm (red filter) in a
cuvette l = 5 mm.
Calculation: Determine of inorganic phosphate quantity
using the calibration curve:
                           E1 =                  C1 =
 Use  the  obtained  value  (C1)  for  calculation  of  the  daily
excretion of phosphate with urine:   D = 1500 ml/ 24 h
C= C1 × 1,5 =            g/24 h;           1,5 – coefficient.
Norma: about 1-5 g / 24 h.
Clinical-diagnostic means: The quantity of inorganic phopha-
tes excreted with urine increases essentially in leukaemia, infe-




Mineral components of dental tissue: representatives, forms,
role.
Organic components of dental tissue: representatives, role.
Structural  organization  of  the  hard  tissues  of  teeth  (enamel
and dentine).
Biochemical mechanism of the teeth mineralization.
Normal biochemical processes in the teeth.
Biochemical processes that take place in the development of
dental caries.
Fluorosis of teeth: pathogenesis, biochemical disorders.
LESSON 37
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Biochemistry of parodont. Biochemistry of saliva
Experiment 1.  Identification of thiocyanate-ions (SCN-)
in the saliva.
Lactoperoxidase uses SCN-ions in presence of Cl-ions and
H2O2 for production of OSCN-ions with stronger protective anti-
microbial action. SCN-ion is also a product of CN-ion detoxica-
tion.
Method principle: Thiocyanate-ions combine with FeCl3
with production of red coloured complex.
Procedure: Saliva may be used for assay. Put 5-10 drops of
saliva and 1 ml of FeCl3 into the test-tube, mix it.
Conclusion:
Clinical diagnognostic means: The content of thyocyanate
increases in patients with gingivitis, parodontitis.
Experiment 2. Identification of salivary peroxidase.
Peroxidase is an important enzyme of saliva with protective
antimicrobial and antioxidative properties.
Method principle: Peroxidase catalyzes benzidine in presence
of H2O2 to p-chinondiimine, green coloured substance.
Procedure:  Put 5-10 drops of saliva, 5-10 drops of 1%
benzidine solution and 5-10 drops of H2O2 into the test-tube. Mix
it.
Conclusion:
Clinical diagnostic means:  Salivary peroxidase activity in-
creases in patients with gigivitis, parodontitis.
Self-preparing questions:
1. Periodont. Main chemical compounds, their characteris-
tics and biological role.
2. Physiological biochemical processes that take place in the
periodont.
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3. Biochemical processes that take place in the pathology of
the paradont. The role of the inflammation mediators and immune
system. Gingivitis, parodontitis.
4. Dental plaque, its chemical composition. Main biochemi-
cal processes in the plaque. Correlation with the caries formation
and periodontal pathologies.
5. The role of vitamins in the metabolism of dental tissues
and soft tissues of the mouth (vitamins A, D, C, etc).
6. Gingival liquid: causes of its appearance, chemical com-
position and its role.
7. Saliva: sources, chemical composition, physic-chemical
properties and its role. Clinical diagnostic means of salivary
components in medicine and dentistry.
LESSON 38
Colloqiu: Biochemistry of connective, tooth and bone
tissues. Saliva
1. The cells of connective tissue: the representatives, their
biological role.
2. The extracellular matrix of the connective tissue:
§ proteins (collagen, elastin): the particularities of bio-
chemical structure, biosynthesis and degradation, biological role.
§ glucosamine glycans: representatives, their structure,
physico-chemical properties, biological role, biosynthesis;
§ proteoglycans: composition, structure, functions and
metabolism.
3. Acquired qualitative modifications (scurvy, diabetes); ge-
netic qualitative modifications: collagenoses, mucopolysacchari-
doses, the causes of biochemical manifestation.
4. The cells of the bone tissue: the representatives, their bio-
logical role.
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5. Mineral  components  of  the  bone  tissue:  the  main  anions
and cations, their structural organization, minor ions and olygo-
elements, their role.
6. Organic compounds of the bone tissue: fibrilar and non-
fibrilar proteins,  proteoglycans, carbohydrates and lipids, their
structural organization and biological role.
7. Formation and resorbtion of the bone: mechanisms, enzy-
mes, regulation. The role of vitamins D, C, and hormones (calci-
tonine, parathyrin) in these processes.
8. The pathology of bone tissue metabolism: age-dependent,
osteoporosis, skeletal fluorosis.
9. Mineral components of dental tissue: representativies,
forms, role.
10. Organic components of dental tissue: representativies,
role.
11. Structural  organization  of  the  hard  tissues  of  the  teeth
(enamel and dentine).
12. Biochemical mechanism of the teeth mineralization.
13. Normal biochemical processes in the teeth.
14. Biochemical processes that take place in  development
the dental caries.
15. Fluorosis of teeth: pathogenesis, biochemical disorders.
16. Periodont. Main chemical compounds, their characteris-
tics and biological role.
17. Physiological biochemical processes that take place in
the periodont.
18. Biochemical processes in the pathology of the paradont.
Role of the inflammation mediators and immune system. Gingi-
vitis, parodontitis.
19. Dental plaque, its chemical composition. Main bioche-
mical processes in the plaque. Correlation with the caries forma-
tion and periodontal pathologies.
20. The role of vitamins in the metabolism of the dental and
soft tissues of the mouth (vitamins A, D, C, etc).
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21. Gingival liquid: causes of its appearance, chemical
composition and its role.
22. Saliva: sources, chemical composition, physic-chemical
properties and its role. Clinical diagnostic means of salivary
components in medicine and dentistry.
BIOCHEMICAL INDICES
Chemical composition of blood plasma
I. Proteins
1. Total protein                     65-85 g/L
2. Albumins                          35-50 g/L
3. Globulins                          25-35 g/L
4. Fibrinogen                         2.0-7.0 g/L
5. Haptoglobin                      0.28-1.90 g/L
6. Prothrombin                     10-15 mg/dL
7. Plasminogen                     1.4-2.8 mmol/L  (20-40 mg/dL)
8. Transferrin                        19.3-45.4 mmol/L   (170-400
mg/dL)
9. Ceruloplasmin                  1.52-3.31 mmol/L  ( 23-50 mg/dL)
10. b-Lipoproteins                3.0-6.0 g/L  (300-600 mg/dL)
HDL – high density lipoprotein (a-LP)  1.063-1.210
mmol/L  (80-400 mg/dL)
LDL – low density lipoprotein (b-LP)    1.006-1.063
mmol/L  (360-640 mg/dL)
II. Enzymes
1. Alanyl aminotransferase (ALT)           0.16-0.68 mmol/h ×L
or  (15-75 IU/L) (glutamate pyruvate transferase, GPT)
2. Aspartate aminotransferase (AST)        0.10-0.45 mmol/h × L
or  (10-50 IU/L) (glutamate oxaloacetate transferase, GOT)
3. Lactate dehydrogenase                           0.8-4.0 mmol/h × L
4. Creatine kinase                    < 1.2 mmol/h × L   or  (< 90 IU/L)
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5. Fructose-biphosphate aldolase (F-1,6-PA)   3.6-21.8 mmol/h ×
L
6. Acetylcholine esterase                          160-340 mmol/ h × L
7. a-Amylase                              15-30 g/h × L   or   (< 300 IU/L)
8. Alkaline phosphatase                          30-150 IU/L
9. Acidic phosphatase                          < 62 nkat/L
10. g-Glutamyl transferase (gGT or GGT)   < 60 IU/L
III. Nonproteinic nitrogenous compounds
1. Nitrogen residual (nonproteinic)        19.5-30.0 mmol/L
2. Nitrogen of amino acids                     3.5-5.5. mmol/L
3. Creatine                                              15-70 mmol/L
4. Creatinine 60-150 mmol/L
5. Urea                                                   3.3-6.7 mmol/L
6. Uric acid                                            0.1-0.4 mmol/L
7. Bilirubin total                                    8-20 mmol/L
8. N-Acetylneiraminic acid                  1.8-2.2 mmol/L
9. Histamine                        7.99-71.94 nmol/L  (0.2-0.8 mg/dL)
10.  Adrenalin                        1.91-2.46 nmol/L   (0.35-0.45 mg/L)
11.  Serotonine                        0.3-1.7 mmol/L   (5.0-30.0 mg/dL)
12.  Thyroxine                       64.36-141.59 nmol/L    (5-11mg/dL)
IV. Carbohydrates and metabolites
1. Glucose                                           2.8-6.0 mmol/L
2. Lactate                                            0.5-2.0 mmol/L
3. Pyruvate                                      < 0.1 mmol/l
4. Citric acid                      88.5-156.1 mmol/L   (1.7-3.0 mg/dL)
V. Lipids and metabolites
1. Total lipids                                 4.0-8.0 g/L
2. Triacylglycerides                        0.5-2.1 mmol/L
3. Total phospholipids                   2.0-3.5 mmol/L
4. Total cholesterol                        4.0-8.6 mmol/L
5. Free fatty acids                          0.3-0.8 mmol/L
6. Ketone bodies                           100-600 mmol/L
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VI. Mineral components
1. Sodium (Na+)                              135-155 mmol/L
2. Potassium  (K+)                          3.6-5.0 mmol/L
3. Chlorides  (Cl-)                           97-108 mmol/L
4. Calcium (Ca2+)                           2.25-2.75 mmol/L
5. Phosphate inorganic                   0.8-1.4 mmol/L
6. Magnezium (Mg2+)                    0.7-1.0 mmol/l
7. Sulphates                                    0.4-0.6 mmol/L
8. Iron (Fe)                                   14-32 mmol/L  (65-175 mg/dL)
9. Copper (Cu)                               12-19 mmol/L
10.  Zinc (Zn)                                   12-20 mmol/L
11.  Ammonia                                   10-47 mmol/L
Indices of blood
1. Hemoglobin: males                       130-180 g/L (13-18 g/dL)
                            females                    120-160 g/L (12-16 g/dL)
2. Hydrogen ion: arterial blood         35-46 nmol/L  (pH= 7.36-
7.44) (38o C)
3. Oxygen  (Po2) in arterial blood:   11-15 kPa  ( 85-105 mm
Hg)
4. Bicarbonate total (CO2)               22-30 mmol/L
5. Carbon dioxide  (Pco2) in arterial blood: 4.5-6.0 kPa  (35-46
mm Hg)
Indices of urine
Density (r)                                     1.017-1.020
pH                                                    5.7-6.5
Urea                                         220-609 mmol/24 h  (20-35 g/24 h
Creatinine                              7.1-17.7 mmol/24 h ( 0.8-2.0 g/24 h
Uric acid                       1.60-3.54 mmol/24 h  ( 270-600 mg/24 h)
Indican                                            46.0-56.4 mmol/24 h
Calcium (Ca2+)            2.50-6.25 mmol/24 h   ( 100-250 mg/24 h)
Cloride ion (Cl-)
Ketone bodies:  acetone                 400-600 mg/L
                          acetoacetic acid    100-200 mg/L
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Chondroitine sulphates                  2.7-7.5 mg/24 h
Pyruvic acid                    113.7-283.9 mmol/24 h (10-25 mg/24 h)
Uropepsinogen                       150-300 IU/24 h  (1.5-3.0 mg/24 h)
a-Amylase (diastase):                 1.0-2.0 IU/ml  (100-200 IU/dL)
               Volgemut’s method:     16-64 IU/L
Adrenalin                                    < 13.3 mg/24 h
Noradrenalin                              < 79.8 mg/24 h
17-ketosteroids:  males           42.48-46.75 mmol/24 h  (12.83±0.8
mg/24 h)
                         female          34.78-39.16 mmol/24 h  (10.61±0.66
mg/24 h)
Indices of saliva
Daily volume (V)                     500-1500 ml   (500-1500 ml/24 h)
pH                                                  6.07-7.9
Density (r)                                    1.08-1.32
Nitrogen-contaning organic substances
Proteins                                         1.4-6.4 g/L
Mucine                                          0.8-6.0 g/L
Ammonia                                      0.01-0.12 g/L
Urea                                              0.14-0.75 g/L
Uric acid                                       0.005-0.029 g/L
Creatinine                                     0.005-0.750 g/L
Choline                                         0.005-0.036 g/L
Nitrogen-noncontaning organic substances
Glucose                                        0.10-0.30 g/L
Citric acid                                 < 0.020 g/L
Lactic acid                                   0.01-0.05 g/L
Cholesterol                                  0.025-0.500 g/L
Inorganic substances
Sodium (Na)                               5.2-24.4 mmol/L
Potassium (K)                            14-41 mmol/L
Calcium (Ca)                              2.3-5.5 mmol/L
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Chlorides  (Cl-)                           15.1-31.6  mmol/L
Phosphate inorganic                    0.080-0.217 g/L
Bicarbonate (HCO3-)                  2.13-13.00 mmol/L
Fluor (F-)                                    0.8-2.5 g/L
Brom (Br-)                                  0.2-7.1 mg/L
Tiocianate (SCN-)                      0.12-0.33 g/L
Magnezium (Mg2+)                    0.16-1.06 mmol/l
Sulphates                                    0.04-0.2 g/L
Copper (Cu)                               0.5-7.6 mg/L
Zinc (Zn)                                   0.06-0.80 g/L
Vitamines
Thiamine (B1)                            0.7 mg/dL
Riboflavin (B2)                          5.0 mg/dL
Pyridoxine (B6)                         60 mg/dL
Nicotinic acid (PP)                   3.0 mg/dL
Pantotenic acid                          8.0 mg/L
Ascorbic acid (C)                      0.58-3.78 mg/L
Biotin (H)                                 0.08 mg/dL
Phyllochinon (K)                     1.5 mg/dL
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